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Abstract 
 
Enamel demineralisation or white spot lesions (WSLs) is a risk for all 
patients undergoing fixed appliance orthodontic treatment (FAOT) with no 
consensus with regards to prevalence, risk factors, prevention and 
treatment. Slow-release fluoride glass devices (SRFGDs) have been shown 
to clinically prevent caries without relying on patient’s compliance, therefore 
their effectiveness in preventing WSLs during FAOT was investigated.   
An in-vitro exploratory study investigated fluoride (F) and phosphate (PO4) 
release from different types of powder from SRFGDs incorporated into a 
composite resin bonding material. Samples were stored in artificial saliva 
and assessed with ion chromatography for up to six months. Three types of 
powder showed high F release to maximise caries prevention and low PO4 
release to minimise degradation of powder.  
A questionnaire was emailed to orthodontists’ members of the British 
Orthodontic Society. For majority of responders the key factors to the 
problems related to WSLs are clinical examination, photographs, F, oral 
hygiene, diet and duration of FAOT.  
A double-blind, randomised clinical study with orthodontic patients randomly 
allocated to SRFGDs or placebo devices threaded onto the orthodontic wire 
was conducted. Cross-polarised digital photographs of the maxillary 
permanent central and lateral incisors and canines were taken for 63 
subjects at the start and for 40 subjects at the end of the study. One 
examiner assessed photographs for presence and severity of WSLs. 
Majority of volunteers and the smallest number of refusals lived in the most 
deprived areas according to the Multiple Deprivation Index. Use of SRFGDs 
would decrease severity by preventing 2.88 times more teeth compared to 
use of 225 ppm F mouth-rinse once daily and 1,450 ppmF tooth-paste twice 
daily. Duration of FAOT and increased gingival index at the start of FAOT 
increased significantly the risk of developing WSLs. 
SRFGDs were effective in preventing teeth with WSLs during the course of 
FAOT. 
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1 Introduction 
Enamel demineralisation or the so called “white spot lesion” (WSL) is the 
precursor stage of dental caries and a constant risk of fixed appliance 
orthodontic treatment (FAOT) hence of great importance to both dentists and 
orthodontists. The latest statistical data report that nearly 4.3 million new 
orthodontic courses of treatment were undertaken during the period of 
March 2011-2012 in England alone, an increase of 32,000 or 0.7% (Health 
and Social Care Information Centre, 2012). These numbers clearly 
demonstrate not only a great number of new cases each year but an 
increasing trend as well. If we were able to quantify the risk of developing 
caries in these patients then we might be able to quantify any costs of repair 
and/or any costs of prevention of such lesions for any effective method.   
Introduction of brackets and bands creates plaque stagnation areas inducing 
changes in the oral environment, mainly increasing the intra-oral bacteria 
counts in both plaque and saliva (Arneberg et al., 1984), resulting in an 
increased caries risk compared to the general population (Lundstrom and 
Krasse, 1987). As a result there is extensive literature into the clinical 
appearance, histology, diagnosis and of course prevention and 
treatment/arrest of such lesions.  
Comprehensive FAOT usually takes about two years to complete which 
maximizes opportunities for demineralisation to occur with all the aesthetic 
and dental health consequences. Presence of WSLs or frank caries can 
even delay the start of treatment until the lesions are arrested or controlled. 
It also appears that there is a lack of knowledge of the risk of decay among 
parents of children who had FAOT (Pratelli et al., 1996). These factors 
paired with the fact that the aim of most orthodontic treatment is to improve 
aesthetics leaves no doubt that an effective preventive regime is imperative 
to avoid new problems.  
Such lesions can themselves grossly compromise dental appearance 
especially due to their likely location when associated with fixed appliances. 
Patients can therefore be left considerably worse off than if treatment had 
never been started. For example, if treatment has to be abandoned due to 
dental health problems such as development of caries, patients may have 
had extractions undertaken purely for orthodontic reasons and can then be 
left with residual spaces as well as much of the original malocclusion 
together with unsightly, carious lesions.  
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With regards to prevention of WSLs, fluoride (F) has been given much 
attention as it is accepted worldwide to be the main factor for the prevention 
of dental caries. However the main problem with use of F is patients’ 
compliance especially during the often lengthy courses of FAOT. If the 
problem is not solved it is likely to result in early termination of treatment due 
to further development of carious lesions that may need restorative 
intervention.  
In order to overcome the obstacle of poor compliance, the slow-release 
fluoride glass devices (SRFGD) have been developed in Leeds, West 
Yorkshire, U.K. These devices originally comprised a glass bead attached to 
the dental enamel hence overcoming the need for patient’s compliance. The 
F is slowly and continuously released in the mouth for up to 18 months 
hence it can achieve its maximum preventive effect by being constantly 
present at the enamel-plaque interface (Toumba and Curzon, 1993). This 
study aims to investigate prevention of enamel demineralisation in patients 
undergoing FAOT by employing a modified SRFGD, designed for 
orthodontic use. 
 
3 
 
2 Literature Review 
2.1 Assessment of WSL(s) 
WSL(s) is one of the names used to describe demineralised dental enamel, 
recognised in studies as early as 1937 (Noyes, 1937). Other names used 
are early caries, early enamel caries, enamel demineralisation, chalky white 
spot, early lesions etc.  
Clinically these lesions can be seen with the naked eye under bright white 
light and when dental enamel has been air-dried as a white opaque area. 
Water is replaced by air in the porous demineralised enamel; the lower 
refractive index of air compared to water results in a different appearance. 
The most common methods and indices that have been used to describe 
and/or document such lesions clinically are listed in Table 2-1. 
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Table 2-1: Indices used for clinical examination of WSLs 
Index Score 
(von der Fehr, 1961) 
Caries Index 1961 
0= surface appears intact 1=limited greyish tinge, with or 
without accentuated perikymata 
2=perikymata well 
accentuated, in some areas 
confluencing into greyish-
white spots 
3=pronounced white 
decalcification 
(Zachrisson and 
Zachrisson, 1971b) 
0=surface appears  
intact 
1=whitish demineralisation 
without cavitation of the enamel 
2=whitish demineralisation 
with the beginning of 
cavitation of the enamel 
3=cavitation that cannot 
be removed by cautious 
grinding of the enamel 
(Curzon and Spector, 
1977) 
OO= absent 
 
O1=white opaque flecks, spots, 
patches involving <25% of labial 
enamel surface 
O2=white opaque flecks, 
spots, patches involving 25-
50% of labial enamel surface 
O3=white opaque flecks, 
spots, patches involving 
>50% of labial enamel 
surface 
(Gorelick et al., 1982) 1=no white spot 
formation 
2=slight white spot formation 
 
3=excessive white spot 
formation 
4=white spot formation 
with cavitation 
(Mizrahi, 1982) 
0=no enamel opacity. An 
opacity of <1 mm in 
length or diameter is 
considered absent 
1=an opacity covering up to 1/3 of 
the surface area. 
2=an opacity covering from 
1/3 to 2/3 of the surface area 
3=an opacity covering 
from 2/3 to the full surface 
area 
Enamel Defect 0=no WSL 1=WSL involves less than 1/3 of 2=WSL involves more than 3= WSL involves more 
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Score, (Artun and 
Brobakken, 1986) 
 the vestibular enamel surface 
area outside the area covered by 
bracket and bonding material 
1/3 but less than 2/3 of the 
vestibular enamel surface 
area in question 
than 2/3 of the vestibular 
enamel surface area in 
question 
(Geiger et al., 1988) 1=slight white spot 
formation 
2=severe white spot formation 
 
3= excessive white spot 
formation (cavitation) 
 
Enamel 
Decalcification Index, 
(Banks and 
Richmond, 1994) 
0 = no decalcification 
 
1 = mild, but clinically visible 
decalcification affecting <50% of 
the area 
2=moderate to severe 
decalcification  extending 
over >50% of the area 
3 = decalcification 
covering the  whole area 
or with obvious surface 
breakdown or caries 
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Despite the subjective nature of all these indices, they have been used in 
many in-vivo studies, even when examiner reproducibility is unreported. 
Their main advantages are that they are easy and cheap to use in any 
dental setting and in epidemiological studies requiring minimal training. 
Several modifications of the above can be found whereas other indices have 
been developed and used for the purpose of one study only (Kindelan, 1995, 
Melrose et al., 1996, Kindelan, 1997, Wenderoth et al., 1999, Andersson et 
al., 2004, Andersson et al., 2007).   
More sophisticated methods have been developed for caries detection and 
quantification. They employ fluorescent techniques based on light scattering 
e.g. quantitative light fluorescence (QLF™) and DIAGNOdent with extensive 
literature to support them. Their main advantage is the ability to provide 
quantitative data but the equipment is expensive, requires training and is not 
easily available outside a hospital setting.    
Photographs (either digital or slides with or without magnification) and 
computer based image analysis can document WSLs but also provide data 
on examiners’ reproducibility. They are easily obtained with minimal training 
and can be easily standardised; they use inexpensive equipment but do not 
allow quantification of the area under examination without other technology 
being applied (Gorelick et al., 1982, Mitchell, 1992a). Slides performed 
worse than digital photos in-vitro and since there was poor agreement 
between the two techniques (86%) they should not be combined (Benson et 
al., 2005).  
 The problem of detecting changes in artificial WSLs over time and 
flash reflection was also examined in-vitro with good reproducibility when 
WSLs were assessed from conventional photos. Use of different software 
showed no evidence of systematic error but it was discussed that flash 
masking should be considered as well as a 20º angle to reduce flash 
reflection (Benson et al., 2000). In another study there was an almost linear 
relationship between number of days the area was exposed to a cariogenic 
solution and mean grey level of the WSLs assessed with digital photographs 
(Willmot et al., 2000).  
The use of cross-polarised photography has reduced surface flash reflection 
allowing improved visualization of enamel defects (Robertson and Toumba, 
1999, Willmot et al., 2000). Other studies do not favour use of cross-
polarised photographs for early caries lesions due to lack of contrast and 
prints appearing “completely flat” (Hill and Geddes, 1975) or because it is 
difficult to focus and there is restricted flash output (Fleming et al., 1989). 
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Digital photographs easily allow use of image analysis software to assess 
surface area of WSLs. In-vitro comparison of QLF™ to digital photographs 
showed good agreement when measuring the demineralised area, therefore 
it is possible to combine the techniques (Benson et al., 2003a, Benson et al., 
2003b). There is evidence to support use of cross-polarizing photographs in 
order to reduce flash reflection even when brackets are in place allowing for 
a 20° angle of the camera (Livas et al., 2008). Non-polarised photographs on 
the other hand need to be taken at a 20° angle to reduce flash reflection 
(Benson et al., 2000).        
 
2.2 Rate of development of WSLs 
A frequently quoted ex-vivo study showed that demineralisation around 
orthodontic brackets can develop within four weeks confirmed by micro-
hardness (MH) testing (O'Reilly and Featherstone, 1987). Clinically WSLs 
were visible within five weeks (Holmen et al., 1988) and in a split-mouth 
design study with longer duration (6-13 weeks) 73% of surfaces developed 
WSL within the study period (Twetman et al., 1997). These studies show 
that WSLs in orthodontic patients can develop very quickly at both 
microscopic and clinical level, reflecting  the changes in the oral micro-flora 
when fixed appliances are introduced in the oral environment (Lundstrom 
and Krasse, 1987).  
 
2.3 Risk factors for developing WSLs 
Pre-existing WSLs have been identified as a risk factor in some studies 
(Zimmer and Rottwinkel, 2004, Lovrov et al., 2007) but not in another study 
(Stecksen-Blicks et al., 2007).  
The role of patient selection and education has been discussed in a 
review (Mitchell, 1992b). In an in-vivo prospective study in a private practice 
two regimes for preventing WSLs were compared in a high and a low caries 
risk group of patients (Zimmer and Rottwinkel, 2004). These groups were 
determined by assessing several factors, namely plaque index, approximal 
plaque index, gingival index, DMFT/dmft and initial lesions. The rigorous 
prevention group showed statistically significant results for both caries risk 
groups however participation was voluntary, introducing bias. The authors 
report a sensitivity of 75% and specificity of 88% for their assessment of 
caries risk proving their clinical validity.  
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Multiple regression analysis showed a weak correlation of WSL to 
frequency of TB and F use (table salt, tables, TP, gel and MW) and a 
highly significant relationship with the clinical attachment level (p<.01, 
multiple regression) with the incidence of WSLs of teeth increasing from 
0.3% to 9.8% depending on the intensity of the prevention program (Lovrov 
et al., 2007).   
With regards to age, most studies failed to find a correlation (Zachrisson and 
Zachrisson, 1971b, Boersma et al., 2005), however one prospective cohort 
study showed a lower incidence of WSLs for patients aged 19-24 years. 
However the cohort was not followed throughout FAOT, hence only one 
assessment was possible (Kukleva et al., 2002). 
There is no clear answer for gender, with some studies finding that boys 
develop significantly more WSLs than girls (Zachrisson and Zachrisson, 
1971b, Kindelan, 1995, Boersma et al., 2005) whereas other studies showed 
either the opposite (Mattousch et al., 2007) or no significant difference 
(Millett et al., 1999, Karadas et al., 2011).  
Some clinical trials found no correlation with length of FAOT (Zachrisson 
and Zachrisson, 1971b, Boersma et al., 2005, Karadas et al., 2011) but 
others have reported that after 17 months (Marcusson et al., 1997) or 24 
months (Geiger et al., 1988) there was an increase in WSLs.   
Poor oral hygiene prior to FAOT appears to be a significant risk factor in 
many studies (Zachrisson and Zachrisson, 1971a, Zachrisson, 1972, 
Stratemann and Shannon, 1974, Zachrisson, 1976, Gorelick et al., 1982, 
O'Reilly and Featherstone, 1987, Ogaard, 1989, Boyd, 1992, Geiger et al., 
1992, Gorton and Featherstone, 2003). The Plaque and Gingival Index by 
Löe (Loe and Silness, 1963, Silness and Loe, 1964) has been used in many 
studies to assess oral hygiene (Zachrisson and Zachrisson, 1971a, 
Wenderoth et al., 1999, Zimmer and Rottwinkel, 2004, Boersma et al., 2005, 
Lovrov et al., 2007). Furthermore, visible plaque at 12 weeks after bonding 
was significantly correlated (r=0.214) to the presence of enamel 
demineralisation at the end of FAOT. However the correlation is low, so it 
may not be clinically significant (Ogaard et al., 2001).  
Diet as well as socio economic status have not been much investigated 
but were not found to be correlated to the development of WSL (Boersma et 
al., 2005). 
Compliance with use of F rinse has been reported to be poor in 52% and 
excellent in 27% of subjects when a questionnaire was given to the 
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parents/patients (Geiger et al., 1988). In a clinical trial of patients asked to 
use F rinse once every other day, 21% developed WSLs whereas the 
corresponding number for those who rinsed less frequently was 49%. 
Patients’ compliance with daily use of NaF MW was reported to be full in 
only 13% and good in only 42% of subjects and it was significantly related to 
the presence of WSLs (Geiger et al., 1992) but in a more recent study, use 
of F showed a weak correlation to the presence of WSLs (Lovrov et al., 
2007). It appears that there is an increase in WSLs with less frequent use of 
F rinse despite of the fact that terms like “good” and “poor” compliance do 
not help us quantify the problem. 
A significant increase in both lactobacilli and mutans streptococci counts 
in saliva after insertion of fixed appliances was first reported in 1987 
(Lundstrom and Krasse, 1987). Presence of WSLs has been positively 
related to lactobacilli counts in saliva but not related to mutans streptococci 
(Boersma et al., 2005). The percentage of mutans streptococci in plaque at 
the time of bonding has been reported as a good predictor for future 
presence of WSLs (Ogaard et al., 2001). 
It appears that many potential risk factors have been investigated with 
conflicting results. Patients usually receive oral hygiene instructions with or 
without diet counselling, professional plaque removal and/or F application 
prior to their FAOT, therefore, the prevention package varies. Ideally 
identification of risk factors is possible with case-control studies where 
subjects are matched for confounding variables such as age or gender and 
the risk factor in question is identified in the groups.  
 
2.4 Prevalence and incidence of WSLs 
Over the years, many studies have estimated the prevalence and/or the 
incidence of this problem. In a comprehensive review of the literature figures 
reported to range from 2-96% of patients and 0-24% of teeth (Mitchell, 
1992b). The wide range was mainly attributed to the difficulty in 
differentiating between WSLs and idiopathic lesions resulting in over-
diagnosis. Following this review other studies investigated prevalence of 
WSLs as their primary outcome still with a wide range from 4.2% to 88% of 
teeth (Kindelan, 1997, Ogaard et al., 2001) and from 13% to 85% of subjects 
(Fornell et al., 2002a, Heinig and Hartmann, 2008). A summary of these 
studies is found in Table 2-2. Studies looking into incidence of WSLs from 
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1992 onwards show a wide range from 1.9 to 76.8% for teeth (Le et al., 
2003, Kronenberg et al., 2009) and from 10.7 to 73% for subjects (Banks et 
al., 2000, van der Veen et al., 2010), as seen Table 2-3. But it is difficult to 
draw firm conclusions due to differences in study design, method of 
assessment of WSLs and heterogeneity in using clinical indices to assess 
WSLs.  
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Table 2-2 Summary of studies reporting on prevalence of WSLs from 1992 onwards. 
Study No of 
subjects 
No/group of examined teeth  Detection method Teeth most commonly affected WSL % 
 teeth 
WSL % 
 subjects 
(Banks and 
Richmond, 1994) 
80 1182 Clinical Upper lateral incisors & canines, 
lower canines & second premolars 
31 73 
(Banks and 
Richmond, 1994) 
80 1182 Clinical Upper lateral incisors & canines, 
lower canines & second premolars 
25 75 
(Tebbett, 1995) 45 All erupted teeth Clinical n/a n/a 67 
(Kindelan, 1995) 52 977 Clinical n/a 9.8 44.2 
(Banks et al., 1997) 50 737 (366 experimental and 371 
control teeth) 
Clinical n/a 13.5 
 
50 
(Kindelan, 1997) 42 902 Clinical n/a 4.2 38 
(Ogaard et al., 
2001) 
100 Upper and lower incisors, canines, 
premolars and first molars 
Clinical Upper lateral incisors, lower first 
molars and premolars 
88 
 
n/a 
(Fornell et al., 
2002a) 
39 216 Clinical n/a 7.4 
(16/216) 
13 (5/39) 
12 
 
(Boersma et al., 
2005) 
62 Upper and lower incisors, canines, 
premolars and first molars 
Visual examination of 
QLF images on PC 
n/a 30 
 
n/a 
(Heinig and 
Hartmann, 2008) 
40 n/a Clinical n/a 9.18 
 
85 
(34/40) 
(No = number, QLF=quantitative light fluoresence) 
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Table 2-3 Summary of studies reporting on incidence of WSLs from 1992 onwards. 
Study No of 
 subjects 
No/group of examined 
teeth (as 
 reported in study) 
Detection method Teeth most 
commonly 
 affected  
Duration 
(months±SD) 
WSL  
% teeth 
WSL % 
 subjects 
(Mitchell, 1992a) 24 124 Photographic slides n/a Mean 10.5±4.2 19 n/a 
(Boyd, 1992) (paste) 32/35 All incisors, canines, 
premolars and first 
molars 
Clinical  First molars Mean 26.2 14.4 n/a 
(Boyd, 1992) (paste 
& rinse) 
26/30 All incisors, canines, 
premolars and first 
molars 
Clinical First molars Mean 24.3 10.1 n/a 
(Turner, 1993) n/a 82 Clinical n/a Minimum 12 25  n/a 
(Boyd, 1993) (paste) 32 All erupted teeth Clinical n/a Mean 26.2 14.4  n/a 
(Boyd, 1993) (paste 
& rinse) (paste) 
26 All erupted teeth Clinical n/a Mean 24.3 10.1  n/a 
(Boyd and Rose, 
1994) 
32 All erupted teeth Clinical n/a Mean 26.2 14.4  n/a 
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(Boyd and Rose, 
1994) (paste & 
rinse) 
26 All erupted teeth Clinical n/a Mean 24.3 10.1  n/a 
(Trimpeneers and 
Dermaut, 1996) 
50 417 Photographic slides Upper incisors Mean 21 12.7 
 
n/a 
(Marcusson et al., 
1997) 
60 80 Photographic slides n/a Mean 22 29 n/a 
(Marini et al., 1999) 23 Molars and upper 
incisors 
Clinical n/a Mean 12 n/a n/a 
(Millett et al., 1999) 23 120 Photographic slides Upper lateral 
incisors  
Mean 15.3±3.2 72.4 n/a 
(Gaworski et al., 
1999) 
16 149. Incisors, canines 
and premolars 
Photographic slides n/a Range 12-14 75  
 
n/a 
(Zimmer, 1999) 40 All bracketed teeth Clinical n/a Mean 18.32 9.8 n/a 
(Millett et al., 2000) 45 
 
157 Photographic slides Upper lateral 
incisors  and canines  
Mean 21.3±6.6 26 
 
n/a 
(Alexander and 22 All erupted teeth Clinical n/a Mean 26 3.2 n/a 
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Ripa, 2000)  
(Banks et al., 2000) 45 740 Clinical Upper lateral 
incisors, lower 
second premolars 
Mean 20.4±7.92 26 
 
73 
(Mattick et al., 
2001) 
21 63 Photographic slides n/a Mean 25.5 n/a n/a 
(Le et al., 2003) 18 47 anterior teeth Photographic slides Upper lateral 
incisors 
Range 12-14 76.8 (36/47) n/a 
(Elaut and 
Wehrbein, 2004) 
45 106 upper anterior teeth Photographic slides Upper lateral 
incisors 
Mean 14 54.7 (58/106) 
 
n/a 
(Ogaard et al., 
2006) 
47 282 Clinical Upper laterals and 
canines 
Mean 18 7.2 (20/282) 
 
n/a 
(Vivaldi-Rodrigues 
et al., 2006) 
10 100 teeth. Upper and 
lower incisors, canines 
and premolars 
Photographic slides n/a Mean 12 Increase of 
WSL index by 
50.83% 
n/a 
(Stecksen-Blicks et 
al., 2007) 
125 2419 surfaces. Upper 
and lower incisors, 
canines and premolars. 
Photographic slides Upper lateral 
incisors 
Minimum 6 n/a 
 
25.7 
16 
 
(Kronenberg et al., 
2009) 
20 Incisors, canines and 
premolars 
Clinical, 
DIAGNOdent and 
QLF images on PC 
n/a Mean 26 1.9 
 
n/a 
(Benham et al., 
2009) 
14 618. All incisors and 
canines. 
Clinical, photographic 
slides and  
DIAGNOdent 
Upper lateral 
incisors  and canines 
Range 15-18 7.11 (22/309) 
 
42.8 
(6/14) 
(Chapman et al., 
2010) 
332 2656. Upper incisors, 
canines and premolars. 
Digital photographs Upper incisors, 
canines and first 
premolars  
Mean 32 36 
 
n/a 
(Shungin et al., 
2010) 
59 (30 at 
12 years) 
236 (120 at 12 years). 
Upper laterals and lower 
canines. 
Digital photographs n/a Median 20.4 Sum areas 
 
n/a 
(van der Veen et al., 
2010) 
28 All bracketed surfaces Digital photographs 
and QLF images on 
PC 
n/a Mean 18.1±5.5 20.7 (11/53) 
 
10.7 
(3/28) 
(No=number, n/a=non-available, QLF=quantitative light fluorescence) 
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2.5 Teeth most commonly affected by WSLs 
It has been reported that FAOT affects location of caries but does not 
increase its prevalence i.e. caries found on anterior teeth and on facial 
surfaces (Zachrisson, 1976). Whilst there is variation in the literature as to 
which teeth are most commonly affected as seen in Table 2-4 (Geiger et al., 
1988, Banks and Richmond, 1994, Marcusson et al., 1997, Ogaard et al., 
2001) almost all studies agree that the gingival region is the area at higher 
risk (Mizrahi, 1982, Mizrahi, 1983, Twetman et al., 1997). 
In a review of seven studies, the prevalence of WSLs in the orthodontic 
population ranged from 8.5-44% for anterior teeth and 8-71% for molars 
(Linton, 1996). Molars therefore appear to be more vulnerable but bands are 
commonly placed on these teeth rather than brackets hence they have a 
different micro-environment whilst undergoing FAOT. 
Data on the location of WSLs is shown in Table 2-4. It shows that in recent 
studies, the anterior teeth are commonly affected and, together with the fact 
that anterior aesthetics have become more important, it highlights the need 
to investigate more effective WSL prevention methods.  
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Table 2-4 Teeth most commonly affected by WSLs. 
Study Teeth (FDI notation) 
(Meyers, 1952) 12, 22, 11, 21 
(Zachrisson and Zachrisson, 1971b) 16, 26, 36, 46 
(Mizrahi, 1982) 16, 26, 36, 46 
(Geiger et al., 1988) 16, 26, 36, 46 
(Ogaard, 1989) 16, 26, 36, 46 
(Boyd, 1994) 16, 26, 36, 46 
(Banks and Richmond, 1994) 12, 22, 13, 23, 33, 43 
(Trimpeneers and Dermaut, 1996) 12, 11, 21, 22 
(Marcusson et al., 1997) 12, 22 
(Millett et al., 1999) 12, 22 
(Wenderoth et al., 1999) 12, 22 
(Banks et al., 2000) 12, 22 
(Tobin, 2001) Thesis 12, 22 
(Ogaard et al., 2001) 36, 46, 34, 35, 44, 45, 12, 22 
 
2.6 Arrest/Repair of WSLs 
Arrest of WSLs has mainly been attributed to salivary repair because it is 
supersaturated with calcium-phosphate salts identical to enamel 
hydroxyapatite (Gron, 1973). However, very rarely do we observe direct 
deposition of salts onto dental enamel, possibly because salivary 
phosphoproteins rich in proline have been found on the enamel pellicle, 
inhibiting crystal growth and spontaneous precipitation of calcium-phosphate 
salts (Hay et al., 1984). This is further supported by studies on the effect of 
acid on enamel surfaces (Garberoglio and Cozzani, 1979), which 
demonstrate that enamel repair after etching is mainly due to masking by 
salivary proteins than mineral deposition.  
A series of in-vitro experiments concluded that although remineralizing 
solutions and/or saliva are supersaturated with respect to enamel apatite, 
the total amount of calcium and phosphate dissolved is so small that after 
precipitation of the dissolved mineral, only 1/20,000 – 1/30,000 of the 
volume of the mineralizing solution is occupied by mineral. There is slow 
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diffusion in and out of the lesion and there is rapid uptake of calcium and 
phosphate by the enamel apatite crystals so the aqueous phase within the 
pores can be presumed to be marginally supersaturated in the deeper parts 
of the lesion. The well mineralized surface layer on the other hand is a 
serious barrier therefore a subsurface area remains hypomineralized even 
after exposure to saliva. Nevertheless, the nucleation of new apatite crystals 
to substitute lost crystals especially in the deepest part of demineralized 
enamel lesions remains an unsolved problem (Larsen and Fejerskov, 1989).   
Etched molars showed the greatest reduction in the body of lesion and tooth 
surface when exposed to a calcium remineralizing solution - as if etching 
provides a “pathway” to the body of the lesion for the remineralizing fluids 
(Flaitz and Hicks, 1994). When daily F TP was added to the remineralizing 
regime, weekly QLF™ measurements showed no difference 
(p >.05, Kruskal-Wallis) but the gold standard – transverse micro 
radiography (TMR) - showed statistically greater remineralization in the 
etched groups (p =.003, ANOVA). Irrespective of treatment, full 
remineralization did not occur and within weeks the process had reached a 
plateau. 
Clinically it has been shown that complete remineralization may occur in 
2.7% (n=10/370) of teeth with WSLs two years after removal of orthodontic 
brackets (Mattousch et al., 2007) although it has been suggested that 
surface abrasion in addition to some re-deposition of minerals is the possible 
explanation (Artun and Thylstrup, 1986). WSLs that have developed quickly 
do remineralize nearly completely and within weeks in-vivo, in the absence 
of F and if the cariogenic challenge has been removed (Ogaard and Ten 
Bosch, 1994). If however the WSLs develop over a period of two to three 
years, then subsurface lesions develop that remineralize extremely slowly 
and, in the presence of F, the surface tends to remineralize more, forming a 
barrier. However, this study used optical scattering only on 14 teeth 
scheduled for extraction (Ogaard and Ten Bosch, 1994).  
Visual examination was compared to laser fluorescence (DIAGNOdent®) 
when F varnish (Duraphat®) was applied weekly for four or eight weeks in 
children with WSLs in the upper anterior teeth. One examiner was calibrated 
to look into activity of the lesion (Nyvad et al., 1999), the dimensions of the 
WSL and the laser fluorescence readings. Results showed that after eight 
weekly F varnish applications there was 50% less active WSLs (Ferreira et 
al., 2005).  
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2.7 The use of lasers for arresting WSLs 
The first report that laser irradiation makes dental enamel acid resistant was 
in 1965 (Sognnaes and Stern, 1965). Argon laser use on dental enamel 
alters the surface characteristics of the crystalline structure of enamel by 
creating micro-spaces that stabilize ions during an acid attack rather than 
allowing them to be lost (Oho and Morioka, 1990, Anderson et al., 2002, 
Elaut and Wehrbein, 2004) SEM showed smooth enamel surfaces with small 
amounts of cracking, suggesting that acid resistance may be due to changes 
of crystallization of the enamel surface (Harazaki et al., 2001).  
Lasers appear to lower the critical pH for enamel dissolution from 5.5 to 4.8 
and to 4.3 in the presence of 0.1ppm F (Hicks et al., 2004) and short-
term  in-situ studies confirmed these results. Premolar pairs scheduled for 
extractions had a single laser exposure that showed after five weeks a 23-
33% (Blankenau et al., 1999) or 44% (p<.05, ANOVA) reduction in lesion 
depth further enhanced to 62%(p<.05, ANOVA) by a  single application of 
0.5% F varnish (Hicks et al., 2004) compared to their control premolars. 
The use of an argon laser on dental enamel with or without pumice/etching 
of premolars extracted after five weeks showed statistically significant less 
surface area (p<.01, ANOVA) and depth (p<.001, ANOVA) of induced WSLs 
when compared with control premolars (Anderson et al., 2002). 
Argon laser (10sec 250mW) was compared to a halogen light (40sec) in a 
clinical split-mouth study for curing a CR (Transbond)  but showed no 
significant difference (p>.05, Cochran and McNemar’s test) in prevention of 
WSLs assessed on photographic slides in n=45 subjects under FAOT for 14 
months (Elaut and Wehrbein, 2004). A Nd-YAG laser combined with 
acidulated phosphate fluoride (APF) solution to treat WSLs showed a 51% 
reduction (p <.05, Mann-Whitney U-test) in the mean WSL area on 
photographs repeated after one year (Harazaki et al., 2001).   
 Even though there are positive signals from in-vitro work there is not 
enough clinical research to support use of laser for WSLs. 
 
2.8 Treatment of WSLs following FAOT 
A recent systematic review reported lack of reliable evidence to support 
effectiveness of remineralizing agents but a number of clinical trials show 
that routine dental home care there is improvement and also that micro-
abrasion appears to be effective (Chen et al., 2013). Another systematic 
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review of treatment of WSLs following FAOT found seven studies with 11 
evaluations, using PubMed and Research Triangle Institute/University of 
North Carolina Evidence Based Practice Center Criteria. Results showed 
that professionally applied F in high-dose and low frequency and at home 
use of low-dose, high frequency F is justified (Bergstrand and Twetman, 
2003). An ex-vivo study showed that daily use of a neutral 0.2% NaF rinse 
may decrease the surface area but will not inhibit WSLs whereas a F (0.6% 
F-) MW with low pH of 1.91 managed to inhibit the lesions, hence they 
proposed that high concentrations of F will arrest the lesion but prevent 
complete repair (Ogaard et al., 1988). A clinical trial compared placebo F-
rinse and TP to use of 50ppm F rinse twice daily and placebo TP (Willmot, 
2004). Interestingly both groups showed a reduction (p >0.05, 2-side t-test) 
by half in the lesions’ size at 26 weeks raising questions about the role of F 
altogether since the control group appear to have no exposure to F at all.  
Application of 18% hydrochloric acid and pumice abrasion (Croll and 
Cavanaugh, 1986) for treatment of WSLs showed a reduction in the WSL 
area by 83% on digital photographs. It is likely that the sample was biased,  
because the majority of eligible patients declined participation (42/50 or 
84%) and 7/8 volunteers were females (Murphy et al., 2007).  
Many clinical studies have investigated Tooth Mousse or casein 
phosphopeptide-amorphous calcium phosphate complexes (CCP-ACP®). 
One study reported significant improvement in the visual clinical scores, with 
almost three times (p <.01, chi-square) as many WSLs improving in the 
group using  Tooth Mousse twice daily for three months compared to a 
group using once daily F rinse for six months. The examiners were not 
blinded to the intervention therefore it is possible that there was bias 
especially since a subjective method of assessment was employed (Ardu et 
al., 2007). 
All other clinical studies found no difference when Tooth Mousse was 
compared to F MW and WSL were assessed with a light fluorescence 
method (DIAGNOdent®) (Andersson et al., 2007). Similar results when 
Tooth Mousse was compared to a placebo (Bailey et al., 2009) or to F TP 
(Brochner et al., 2011) or to TP containing calcium (Adriaens et al., 1990). 
All studies used light fluorescence methods to assess WSL except for one 
study which used ICDAS II criteria (Bailey et al., 2009). Micro-abrasion 
performed better in a clinical study (Fornell et al., 2002b) and in an in-vitro 
study on bovine enamel (Nazir et al., 2011). 
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Another paste (Enamelon®) was compared to TB in a non-randomised 
clinical study and after three months there was a significant decrease (p<.01, 
covariate analysis) in the WSL area measured with a dental probe (Kleber et 
al., 1999). 
Other studies have found no significant differences between oral hygiene 
instruction given every three months compared to professional tooth 
cleaning (p=.087, three way ANOVA) (Aljehani et al., 2006) and bleaching to 
weekly F gel applications (p>.05, Mann-Whitney U test) (Knosel et al., 2007). 
Bleaching resulted in a more uniform look to the enamel surface and all 
participants appeared to be satisfied with the appearance but 30% of them 
reported hypersensitivity.  
In 18 teeth with WSLs, a resin infiltration technique was used and 
photographs taken after one week showed that 11 of the 18 teeth were 
completely masked and only one tooth remained unchanged. Colour 
differences between sound enamel and WSLs showed a significant 
decrease (p<.05, Wilcoxon signed rank test) (Kim et al., 2011).   
F has been identified as playing a significant role in the treatment of WSLs 
however recent studies use it as control in order to investigate new products 
and/or methods. A reduction in the area of WSLs is a common finding 
without a significant difference between test and control groups. 
Understandably it may be disappointing for a new product/method not to be 
effective but equally these results strengthen the role of F when tested in the 
control group. The only exception that showed significant results was the 
use of Enamelon® TP and Nd-YAG laser combined with an APF solution. 
However, there was no control group hence their effectiveness should be 
interpreted with caution. When subjective clinical indices are combined with 
a lack of blinding then bias is likely to be introduced into the study, 
decreasing validity. 
 
2.9 Restoration of teeth following FAOT 
Data on restorative care are limited even though there is much less 
subjectivity in diagnosing cavities as opposed to diagnosing WSLs and the 
majority of indices have a corresponding score for cavities. This lack of data 
may be because clinicians will stop treatment before a cavity develops or 
even before they fear that a cavity might develop. In the latest literature 
review on prevalence of WSL there is no report of any index on restorative 
care (Mitchell, 1992b). In recent studies restorative care is rarely reported 
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but results range from zero to 4.8% (Mitchell, 1992a) as seen in Table 2-5. 
Possibly the only study where restorative care was clearly reported as a 
primary outcome two years after completion of FAOT5% (n=19/370) of teeth 
with WSLs had restorative work (Mattousch et al., 2007). 
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Table 2-5 Teeth most commonly affected by WSLs as reported in the literature published from 1992 onwards. 
Study No/group of examined teeth  
(as reported in study) 
WSL (%)  
teeth 
Teeth (%) in need of restorative care 
post-FAOT 
(Mitchell, 1992a) 124 19 4.8 
(Boyd, 1992)  (paste) All incisors, canines, premolars and first molars 14.4 0.9 
(Boyd, 1992) (paste & rinse) All incisors, canines, premolars and first molars 10.1 0.8 
(Turner, 1993) 82 25 0 
(Boyd, 1993) All erupted teeth 14.4 2.3 
(Boyd, 1993) All erupted teeth 10.1 1.0 
(Boyd and Rose, 1994) All erupted teeth 14.4 0.9 
(Banks and Richmond, 1994) 1182 31 n/a 
(Tebbett, 1995) All erupted teeth n/a n/a 
(Kindelan, 1995) 977 9.8 n=0 
(Trimpeneers and Dermaut, 
1996) 
417  12.7 n/a 
(Banks et al., 1997) 737 (366 experimental and 371 control teeth) 13.5 n/a 
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(Kindelan, 1997) 902 4.2 n=0 
(Marcusson et al., 1997) 80 29 n/a 
(Marini et al., 1999) Molars and upper incisors 1 tooth 1 tooth 
(Millett et al., 1999) 120 72.4 1 tooth 
(Gaworski et al., 1999) 149. Incisors, canines and premolars 75  n/a 
(Zimmer, 1999) All bracketed teeth 9.8 n/a 
(Millett et al., 2000) 157 26 1.3  
(Alexander and Ripa, 2000) All erupted teeth 3.2 0.2 
(Banks et al., 2000) 740 26 n/a 
(Mattick et al., 2001) 63 n/a n/a 
(Ogaard et al., 2001) Upper and lower incisors, canines, premolars and 
first molars 
88 n/a 
(Fornell et al., 2002a) 216 7.4  n/a 
(Le et al., 2003) 47 anterior teeth 76.8 n/a 
(Elaut and Wehrbein, 2004),  212 upper anterior teeth 54.7  
 
n/a 
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(Boersma et al., 2005),  Upper and lower incisors, canines, premolars and 
first molars 
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n/a 
(Ogaard et al., 2006) 282 7.2 n/a 
(Stecksen-Blicks et al., 2007) 2419 surfaces. Upper and lower incisors, canines 
and premolars 
n/a in graphs 
(Heinig and Hartmann, 2008) n/a 9.18 1.76 
(Kronenberg et al., 2009) Incisors, canines and premolars 1.9 n/a 
(Benham et al., 2009) 618. All incisors and canines. 7.11 n/a 
(Chapman et al., 2010) 2656. Upper incisors, canines and premolars. 36 n/a 
(Shungin et al., 2010) 236 (120 at 12 years). Upper laterals and lower 
canines. 
Sum areas n/a 
(van der Veen et al., 2010) All bracketed surfaces 20.7 n/a 
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3 Prevention of WSLs 
3.1 Systematic reviews of clinical trials for prevention of WSLs 
The long-standing problem of WSLs in orthodontic patients has attracted 
many systematic reviews. Following the first review in 2001 (Bader et al., 
2001) the first Cochrane Systematic review published (Benson et al., 2004) 
had only one study in common in both reviews (Hirschfield, 1978). Another 
systematic review in the same year (Derks et al., 2004) had one study in 
common with the Cochrane review and none with the 2001 review. A review 
published in 2005 (Chadwick et al., 2005) had one study  in common with 
the 2004 Cochrane review, two studies in common with the 2004 review by 
Derks and two other studies in common with the 2001 review. No single 
study was included in all four reviews as seen in Table 3-1. 
The latest updated systematic review published by the Cochrane 
Collaboration in 2013 identified three studies and n=458 participants all 
published from 2005 onwards hence they would not have been included in 
any of the previous systematic reviews (Benson et al., 2013). The study with 
low risk of bias showed moderate evidence that F varnish (Fluor Protector® 
0.1%F) applied every six weeks resulted in an almost 70% reduction in 
incidence of WSLs and number needed to treat of 5.5 (Stecksen-Blicks et 
al., 2007). The study with high risk of bias due to large number of volunteers 
drop-outs showed no statistically significant difference on number of WSLs 
between use of a SRFGDs or a daily F mouth-rinse (225ppmF) (Luther et 
al., 2005). The third study had an unclear risk of bias and reported a 
statistically significant mean increase in the WSL index used when two 
mouth-rinses were used daily. The amine fluoride/stannous fluoride mouth-
rinse (140ppmF, pH 4.5) group performed better compare to the sodium 
fluoride mouth-rinse group (250ppmF) (Ogaard et al., 2006). It appears that 
there is no agreement even between systematic reviews as to which is an 
effective method of preventing WSLs in orthodontic patients. There are 
several possible reasons why this might be as each systematic review is 
discussed in detail.  
There are different levels to test effectiveness of any given method. Firstly, 
statistically there should be a significant difference in favour of the test 
group. Secondly, and probably more importantly, the question whether this 
difference in numbers mirrors an equally important significant clinical 
difference. Thirdly, cost-effectiveness of the method should ideally be 
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investigated as it is an important factor that could potentially prohibit use of 
the method. With the exception of a few studies that will be discussed later 
the clinical significance of reported differences and cost-effectiveness are 
rarely documented. 
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Table 3-1 Systematic reviews of trials on prevention of WSLs and their 
included studies. 
(Bader et al., 
2001) 
(Benson et al., 
2004) 
(Derks et al., 
2004) 
(Chadwick et 
al., 2005) 
(Benson et 
al., 2013) 
(Hirschfield, 
1978) 
(Hirschfield, 
1978) 
(Banks et al., 
1997) 
(Hirschfield, 
1978) 
(Luther et 
al., 2005)  
(Ullsfoss et al., 
1994) 
(Ogaard et al., 
1986) 
(Alexander and 
Ripa, 2000) 
(Alexander 
and Ripa, 
2000) 
(Ogaard et 
al., 2006)  
(Buyukyilmaz 
et al., 1994) 
(Banks et al., 
2000) 
(Lundstrom and 
Krasse, 1987) 
(Boyd, 1992) (Stecksen-
Blicks et al., 
2007) 
(Boyd, 1993) (Czochrowska 
et al., 1998) 
(Twetman et al., 
1995) 
(Boyd, 1993)  
(Holmen et al., 
1987a) 
(Gillgrass et al., 
2001) 
(D'Agostino et 
al., 1988) 
(D'Agostino 
et al., 1988) 
 
(Ogaard et al., 
1996) 
(Gorton and 
Featherstone, 
2003) 
(Mitchell, 1992a) (Denes and 
Gabris, 
1991) 
 
(Lundstrom et 
al., 1980) 
(Marcusson et 
al., 1997) 
(Marcusson et 
al., 1997) 
  
 (Ogaard et al., 
2001) 
(Millett et al., 
1999) 
  
 (Pascotto et al., 
2004) 
(Turner, 1993)   
 (Twetman et al., 
1997) 
(Trimpeneers 
and Dermaut, 
1996, Turner, 
1993) 
  
 (Dyer and 
Shannon, 1982) 
(Wenderoth et 
al., 1999) 
  
 (Sonis and 
Snell, 1989) 
(Fornell et al., 
2002a) 
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The 2001 review was based on guidelines from the Research Triangle 
Institute – University of North Carolina Evidence-Based Practice Center 
(Bader et al., 2001). Methods of prevention and the arrest of progression of 
non-cavitated dental lesions were investigated. The target group was caries 
active or high caries risk individuals but not necessarily patients undergoing 
FAOT. They identified 22 studies and seven of them, using 11 methods were 
evaluated separately as they all investigated prevention in orthodontic 
patients. The primary question was “...efficiency of methods to reduce 
incidence of caries in teeth with orthodontic bands...” In general the evidence 
for efficacy was characterized as insufficient due to small sample sizes and 
small number of studies per method. They computed a quality score based 
on twelve elements such as blinding, sample size, study type etc; each 
element had a given weight in the calculation of the quality score. Based on 
this assessment the mean quality score of the identified studies was 57/100 
(range 25-80). A statistically significant difference was found when any of the 
following methods were employed: F in any of the following formats: titanium 
tetra-F solution (TiF4); APF and NaF rinse; NaF varnish; SnF2 gel; also 
plaque removal by prophylaxis or a combination of NaF and a CHX rinse 
were proven to significantly reduce mean lesion depth. However the authors 
judged the evidence for efficacy to be insufficient for any given method.  
The Cochrane Systematic review published three years later, (Benson et al., 
2004) concluded that daily use of 0.05% NaF (225ppmF) can reduce the 
severity of WSLs whereas use of GIC for bonding can reduce both the 
severity and prevalence. They identified 15 trials which fulfilled most of their 
criteria. The methods tested in these trials were F (varnish or rinse as NaF, 
SnF2, acid phosphate F); CHX varnish; F elastomeric ligatures and GIC 
and/or RM-GIC bonding material.  
A systematic review based on PubMed and Medline databases only, 
examined studies published from 1970 onwards on methods used to prevent 
caries during FAOT. The prevented fraction (PF) and standard error (SE) 
were used to assess efficacy of methods. Preventive fraction is an index less 
sensitive to the experimental circumstances e.g. age of patients, duration of 
the study and has the following formula: PF = Incidence (control) – Incidence 
(experiment) / Incidence (control). Their aim was to perform a meta-analysis 
but it was not possible due to lack of data homogeneity and insufficient data 
to calculate 95% Confidence Intervals therefore a systematic review was 
undertaken. They identified 15 studies with 16 interventions, grouped into 
four groups. The F group showed no statistically significantly difference but 
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showed positive results for use of 1,500/5,000ppm F TP and 5,000ppm F 
gel. The group of CHX showed again positive results and included either 
40% varnish or 1% preparation placed in mouth-trays either alone or 
combined with 1% thymol. The enamel sealants group showed no positive 
results and the bonding agent group showed an overall PF of 20% for use of 
GIC with a SE of 9% in seven studies but the PF was not deemed 
statistically significant even though they do not explain how they reached 
that conclusion. Surprisingly no studies with use of F mouth rinse were 
included and the results are quite different to the Cochrane Systematic 
Review published in the same year (Derks et al., 2004).  
 A systematic review based on guidelines published by the Centre for 
Reviews and Dissemination at the University of York in U.K. (Chadwick et 
al., 2005) identified seven studies with six trials investigating rinses (APF, 
amine F, NaF), TP (1,500 ppmF) or gel (amine F, SnF2, NaF). They 
concluded that topical F, in addition to use of F TP, reduced the incidence of 
WSLs both in fluoridated and non-fluoridated areas. No specific 
recommendations were made as no method was superior to any other 
although high-potency preparations might offer benefits. Their question was 
prevention of incidence of WSLs and the outcome variable would be severity 
of WSL, DMFT or DMFS. They also used the preventive fraction however it 
was not possible to accurately calculate it due to lack of data. Even though 
they contacted the authors of the included studies, a measure of variance 
and the variance of the differences were not available to be able to calculate 
PF. They also highlighted the importance of developing guidelines on 
reporting results of clinical trials in order to provide material for future use in 
a systematic review and/or meta-analysis.  
The latest literature review into the prevention of WSL highlighted the 
importance of patient education and oral hygiene practices whereas 
methods of F administration (water fluoridation, use of TP, MWs, gels, 
varnishes, within orthodontic bonding agents or in elastomeric modules and 
ligature ties) have been reported to be effective. They also report on CCP-
ACP® (casein phosphopeptide-amorphous calcium phosphate in the form of 
sugar–free chewing gums (Recaldent®), mints (Recaldent Mints®), topical 
gel (Tooth Mousse) which has also shown promising results. They report 
that there is a dose-related increase in enamel remineralisation within 
already demineralised lesions however their ability if any to prevent WSL 
has not been proven yet (Sudjalim et al., 2006). This is the latest review on 
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the subject however it was not a systematic review so the findings have not 
been filtered through strict inclusion/exclusion criteria.  
 Systematic reviews have very strict and rigid inclusion and exclusion 
criteria for the studies they review. This may result in very few studies that 
would meet the criteria and a rather disappointing conclusion where “...no 
studies were found to meet all the inclusion criteria....” Secondly, the 
outcome variables may also differ between reviews investigating different 
things. One review may have as a primary variable incidence of WSLs 
whereas another one may have reduction of surface area of WSLs, however 
both reviews are investigating methods to prevent WSLs but in different 
ways. These variables may not be directly comparable and if not enough 
data is provided in the results e.g. confidence intervals then it is not possible 
to perform any statistical comparisons or use other indices like the 
preventive fraction discussed earlier. It appears that even though the 
systematic reviews have covered the same topic and have assessed the 
same or similar literature, their findings differ because their 
questions/outcome variables were slightly different. Each systematic review 
should be assessed on its own merit and their findings evaluated 
accordingly. Even though there was no agreement on a specific method, F 
appears in all systematic reviews as an efficient method in preventing WSLs 
during FAOT. Other methods identified were plaque removal, CHX rinse 
combined with NaF rinse and use of GIC for bonding.   
 
3.2 Preventing WSLs under orthodontic bands 
The mechanics of the FAOT need the edge of the orthodontic wire to pass 
through a metal tube which can be either welded onto bands or attached 
directly i.e. bonded, onto the tooth. A Cochrane systematic review (Millett et 
al., 2011) (Millett et al., 2011) identified only one study with better results for 
prevention of WSLs when bands were used with GIC compared to tubes 
bonded directly with CR (Nazir et al., 2011).  
 
3.3 Clinical trials in prevention of WSLs 
One of the first clinical split-mouth studies was published in 1952 but FAOT 
was very different then with bands used on all teeth whilst F was not 
routinely used.  Nevertheless, a single application of a chloroform based 
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varnish (Copalite) prevented WSLs assessed visually after six months 
(Meyers, 1952).   
 
3.4 Testing SnF2 in clinical trials for prevention of WSLs 
Studies published in the 1970’s and 1980’s investigating the potential of 
SnF2 had no statistical analysis and subjects were not randomised. Results 
were favourable for daily use of a 0.4% SnF2 gel throughout FAOT which 
lasted from 18 to 24 months (Stratemann and Shannon, 1974). The same 
protocol was followed by n=78 subjects with banded teeth showing again 
favourable results (Shannon and West, 1979).  
Combining 0.4% SnF2 solution with APF solution (0.31% F) also showed 
favourable results for banded teeth (Magness et al., 1979). Even one year 
after band removal results showed that only two subjects and three surfaces 
in the MFP group developed WSLs but there were no lesions in the SnF2 
group (Dyer and Shannon, 1982).  
In the 1990’s studies employed statistical analysis but randomisation was 
used randomly. There was no difference between the groups testing 0.05% 
NaF (225ppmF) rinse once daily alone or in combination with 0.4% SnF2 gel 
applied twice daily (p =.06, ANOVA) but both of them were significantly 
better than the control group using 1,100ppm F TP twice daily (p <.05, 
ANOVA). Conclusion was that probably F TP alone is not adequate to 
effectively prevent WSL (Boyd, 1993). In a follow up paper both Plaque 
(p<.01, ANOVA) and Gingival Index (p<.001, ANOVA) were also significantly 
better for the SnF2 gel group (Boyd, 1994). Elastomeric chains with and 
without SnF2 were replaced every four to six weeks during FAOT 
(mean 1.7 years ± 6 months) in n=94 subjects, following a sample size 
calculation of n=40 subjects per group. One examiner used the Enamel 
Decalcification Index (Banks and Richmond, 1994) and results showed 
significantly less WSLs (p <.001, Chi-square test) in the F chain group at 
subject level (63% Vs 73%) and tooth level (16% Vs 26%). There was no 
randomization of the subjects hence there is bias but there were minimum 
drop outs (6/94) and good follow up of the subjects; a cost analysis would 
also provide more information on the overall effectiveness of the method 
(Banks et al., 2000).  
Even though there is a number of papers published supporting use of 0.4% 
SnF2 as gel, solution or elastomeric chains tested in clinical trial with 
duration ranging from 14 months (Magness et al., 1979) to 24 months (Boyd, 
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1993). Factors which could introduce bias to the studies hence interpretation 
of the results should be treated with caution is the lack of randomisation, the 
lack of statistical analysis in the studies published in the 70’s and 80’s and in 
cases use of indices made and used by the authors for the purposes of one 
study only with no report on examiner’s reproducibility.  
 
3.5 Testing chlorhexidine in clinical trials for prevention of WSLs 
Many clinical studies have tested CHX applied either as a varnish, gel or 
solution during course of FAOT. Results yielded no statistically significant 
difference in caries/WSL assessed by Koch index (Koch et al., 1979, 
Lundstrom and Krasse, 1987) or using Gorelick index (Ogaard et al., 1997, 
Ogaard et al., 2001) or reporting D3/4MFS (Jenatschke et al., 2001). There 
was statistically significant but not clinically significant reduction of salivary 
mutans streptococci counts (Ogaard et al., 1997) when 1% CHX and 1% 
thymol varnish (Cervitec®) was additionally applied to 0.7% F varnish (Fluor 
protector®). Significantly less DMFS was reported in favour of Cervitec® 
varnish application after one year. However the split-mouth design of the 
study indicates that there may have been an overlap effect between the test 
and placebo varnish (Madlena et al., 2000).  
 
3.6 Testing enamel sealants in clinical trials for prevention of WSLs 
The idea that sealing the enamel would protect against WSLs showed when 
tested in-vitro that under the microscope there were small isolated areas 
representing “breaks” in the sealant (Frazier et al., 1996).  
Compared to frequent applications of an enamel sealant every three months 
(Fornell et al., 2002b), it seems that the single application provides some 
protection against demineralisation (Heinig and Hartmann, 2008).The risk of 
enamel breaks that could induce WSLs over the length of FAOT warrants 
further investigation to decide on the cost-effectiveness of this method. To 
this end when a primer was compared to an enamel sealant in order to save 
chair time the results favoured time consuming application of enamel sealant 
(Ghiz et al., 2009).  
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3.7 Other methods tested in clinical trials for prevention of WSLs 
 A number of different methods to prevent WSLs have been tested 
clinically. For some the results were statistically significantly different to 
control groups favouring use of xylitol (Rekola, 1986), electric tooth-brushes 
(Boyd and Rose, 1994), F elastomeric modules (Mattick et al., 2001), 
combined use of Cervitec-Fluor Protector varnish (Kronenberg et al., 2009) 
and lingual brackets (van der Veen et al., 2010).  
Other studies found non-statistically significant differences testing argon 
laser for CR light curing (Anderson et al., 2002) and F slow release intraoral 
devices (Marini et al., 1999). Identification of subjects at high caries risk 
appeared to be an explanatory variable for presence of WSLs in two studies 
from the same group of authors with non-random allocation of subjects into 
groups (Zimmer, 1999, Zimmer and Rottwinkel, 2004). Similar findings were 
reported in a retrospective study assessing DMFS and not specifically WSLs 
(Karadas et al., 2011).  
Interesting point to note is the increased risk of bias in some of these studies 
mainly due to lack of randomisation (Rekola, 1986, Marini et al., 1999, 
Zimmer, 1999, Zimmer and Rottwinkel, 2004). Non-validated indices were 
developed and used for the purpose of a single study (Boyd and Rose, 
1994), subjective assessment of caries risk (Zimmer, 1999, Zimmer and 
Rottwinkel, 2004) and split mouth design that could possibly favour one 
intervention also increase risk of bias (van der Veen et al., 2010, Mattick et 
al., 2001). When objective methods based on light fluorescence were used 
there was no good agreement with the clinical examination therefore results 
need to be carefully interpreted. For example QLF™ showed poor 
agreement with clinical examination and DIAGNOdent did not diagnose any 
WSLs that were diagnosed clinically (Kronenberg et al., 2009). 
 The plethora of methods tested highlights the fact that the problem of 
preventing WSLs has still not been addressed effectively and needs further 
investigation.  
 
3.8 Testing F-materials in clinical trials for prevention of WSLs 
Majority of split-mouth studies comparing various F-releasing bonding 
materials failed to detect a significant difference (Mitchell, 1992a, Turner, 
1993, Millett et al., 1999, Gaworski et al., 1999, Paschos et al., 2009).  
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Studies seen in Table 3-2, favour use of F-CR compared to CR (Sonis and 
Snell, 1989, Trimpeneers and Dermaut, 1996) or diacrylate (Unite) 
compared to GIC (Marcusson et al., 1997) or CR compared to a compomer 
(Millett et al., 2000). One study found difference on a subject level with twice 
as many patients developing WSLs when a chemically cured CR (Lee®) was 
used (14/23 subjects) compared to a light cured CR with F (Orthon®) (5/19 
subjects) (Trimpeneers and Dermaut, 1996).  
 
Table 3-2 In-vivo studies investigating prevention of WSLs by testing  
F- CR bonding materials. 
Study No of  
subjects 
No of 
teeth 
Design Duration 
(months) 
Assessmen
t 
Result – 
WSLs 
Result – 
Bond 
strength 
(Sonis and 
Snell, 1989) 
22 412 split-
mouth 
F-CR 
Vs CR 
25 Visual 
exam 
Curzon 
index (0-3) 
CR 
12.6% 
F-CR 
0%* 
No SSD 
(Trimpeneers 
and Dermaut, 
1996) 
50 836 split-
mouth 
F-CR 
Vs CR 
9-33  Visual 
exam 
No SSD n/a 
 
There seems to be no consensus whether different F releasing bonding 
materials do actually prevent WSLs compared to CR bonding materials but 
there will always be similar studies published as new materials enter the 
market. When bonding materials are tested prevention and/or arrest of 
WSLs would always be a secondary variable. The primary aim of these 
materials is to show adequate bond strength to serve their purpose; that is to 
bond brackets onto human dental enamel.  
 
3.9 Testing F-rinse in clinical trials for prevention of WSLs 
Almost all studies agree that use of F rinse reduces severity/prevalence of 
WSLs depending on the level of compliance. However, few studies report 
differences between products (Hirschfield, 1978, Geiger et al., 1992, Boyd, 
1992). When studies follow their participants for the duration of the FAOT, it 
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mirrors clinical reality. As discussed before, randomisation plays a crucial 
role in clinical studies to avoid bias and this is a point where some studies 
show real weakness (Geiger et al., 1992, Boyd, 1992).   
 
3.10 Testing F-gels and/or varnishes in clinical trials for prevention of WSLs 
 Application of Fluor Protector varnish (0.1% F) every six weeks 
compared to a placebo varnish was tested in a double-blind randomised 
controlled clinical trial in two hospitals over a period of at least six months (6-
30 months). Two examiners used an index (Gorelick et al., 1982) to examine 
digital photographs. Statistically significant higher incidence (25.7%-7.4%) 
(p<.001, Wilcoxon test) and progression (2.6-0.8) of WSL (p<.001, Wilcoxon 
test) was reported for the placebo group. The absolute relative risk (ARR) 
was 18% and number to treat (NNT=1/ARR) was 5.5 i.e. five subjects to be 
treated to obtain one patient free of WSL which indicates a not cost-effective 
method (Stecksen-Blicks et al., 2007). This is one of the few studies 
investigating a method in depth to provide a comprehensive answer with 
regards to effectiveness.  
 
3.11  SRFGDs in orthodontic patients 
In order to achieve the topical action of F i.e. present as a free ion in the 
plaque-enamel interface so as to effectively prevent caries (Fejerskov et al., 
1981), devices that release F slowly but continuously in the mouth were 
developed both in the U.S.A. and in Leeds, U.K. This method was targeted 
at people in high risk caries groups where compliance with TB and use of F 
products was a problem.   
The copolymer membrane F releasing device that has been developed in 
the U.S.A. contains an inner-core of hydroxyethyl methacrylate (HEMA) and 
methyl methacrylate (MMA) copolymer in a 50/50 mixture that contains a 
precise amount of sodium F. The core is surrounded by a HEMA/MMA 30/70 
mixture copolymer membrane which controls the rate of F release. This can 
vary between 0.02 and 1.0 mg F/day. The duration of F release has been 
estimated to last from 30-180 days (Mirth et al., 1982, Toumba and Curzon, 
1993).    
A study published in 1999 (Marini et al., 1999) tested the efficacy of a 
copolymer F releasing device using customized holders and releasing 
0.04mg/day of F has been tested in n=76 patients undergoing FAOT for 
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12 months, with some of them living in a fluoridated area (0.12 ppmF) and 
with no intervention for the control group. No information was provided 
regarding any use of F and/or oral hygiene practices during the study. No 
carious and/or early enamel lesions developed in the devices group whereas 
in the control group with no devices, 2/23 subjects developed caries, one 
requiring restorative care and another developed a WSL. There was no 
significant difference between the two groups for Plaque Index, Gingival 
Index or bleeding on probing. The presence or absence of WSLs was 
assessed by visual clinical examination with no use of any index and no 
report of reproducibility of the method. One out of 53 devices was detached 
with no adverse reactions reported. They also reported that the F in the 
whole saliva (determined using an ion-specific F electrode) increased from 
0.05μg/ml to 0.46μg/ml. However these numbers are not reflected on the 
corresponding graph and also the available data available on the graph go 
as far as 200 days (6.6 months) i.e. short of the 12 months duration of the 
study (Marini et al., 1999).   
The SRFGD was developed in Leeds, West Yorkshire, U.K. and its’ 
last form it is a glass bead attached to a plastic bracket. It contains 13.3% F 
in the form of sodium fluoride (NaF). There are four different relative 
solubility (1, 3, 16 and 50) types depending on the rate of F release. A 
randomized double blind controlled clinical trial in n=174 children showed 
that the SRFGD can elevate salivary F levels to 0.11ppm compared to a 
placebo group whose levels were 0.03ppm after two years (Toumba and 
Curzon, 2005). The same study reported a statistically significant reduction 
in caries increment in the test group (n=31 children who retained the SRFGD 
for two years) associated with 67% fewer carious teeth, 76% fewer carious 
surfaces and 55% fewer occlusal carious surfaces in primary and permanent 
dentition. This was the only study included in a Cochrane systematic review 
(Bonner et al., 2006) however the evidence was considered to be clinically 
weak because statistical analysis excluded 52% of participants who had lost 
the SRFGD during the trial and since the salivary F levels should be 
0.02ppm F to prevent dental decay (Duckworth and Morgan, 1991). 
 The SRFGDs has also been tested in patients undergoing FAOT in a 
pilot study (Tobin, 2001) that showed positive results for the reduction in 
severity and incidence of WSLs. The interim report provides data for 21/70 
subjects that were randomly allocated to SRFGD or no device, all living in 
non-fluoridated area and using 1,100-1,450 ppmF tooth paste twice daily 
and 225 ppmF mouth rinse once daily. WSLs were examined by one 
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examiner using cross-polarizing photographs at the start and end of the 
study. Presence/absence of lesions and white spot area in mm2 were 
assessed using computer image analysis software for the upper anterior 
teeth. An error study was performed to test reproducibility of the image 
analysis method and 20% of the photos were randomly selected and re-
examined by the same examiner with results showing borderline 
acceptability. For the incidence of WSLs there was an overall increase of 
15% (19% in the control group and 8% in the test group) with no statistical 
testing. Lateral incisors were more frequently affected (58%). The control 
group demonstrated a statistically significant increase in the surface area 
compared to the test group (p<.001, paired t-test). However, the difference in 
the mean change of the surface area between the two groups was not 
statistically significant (p=.007, Student’s t-test). The interim report also 
showed that the design of the holder for the device had to be changed since 
there were 19 breakages of the device from the metallic eyelet in eight 
patients (Tobin, 2001). 
 Intraoral devices that slowly and continuously release F have been 
developed and tested for a number of years with two studies investigating 
orthodontic patients. One study appears to have a heterogenous sample 
with some subjects exposed to systemic F in drinking water. Results appear 
to favour the device based on clinical examination. The pilot work cannot 
provide any definitive conclusions but the interim report suggests a positive 
indication in favour of the SRFGD but also highlighted the need for a change 
in the design of the device.    
 
3.12 Testing plaque and saliva in studies investigating prevention of WSLs 
Since plaque and saliva have an important role in the caries process - saliva 
being the medium to transport minerals in the oral environment and the 
presence of plaque being a prerequisite for caries development-it was only 
logical that studies would investigate possible ways to influence these 
vehicles so as to prevent the development of WSLs.  
 
3.12.1 Testing plaque 
Plaque presence was analysed with image analysis software and was 
evident around brackets and near the gum level in n=52 subjects, with 37% 
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of them having plaque present in over 50% of the dentition (Kuklowska et al., 
2011). 
The potential of GIC materials to release F and its’ proximity to the 
areas where WSLs develop resulted in a number of studies investigating the 
effect on plaque.  
In a split-mouth clinical study a GIC (Aqua-Cem, DeTrey®) and a CR 
(Concise, 3M®) bonding material were compared in n=12 children who lived 
in a low F area. The children were asked to use daily 225ppmF rinse. 48h 
old plaque samples were obtained at three, eight, 28 days and six months. 
Results showed significantly lower (p<.01, student’s paired t-test) plaque 
levels of mutans streptococci in the GIC group on all sampling occasions, 
hence it could act as long term F releasing reservoir (Hallgren et al., 1993).  
One study investigated WSLs alongside mutans streptococci counts 
for six months (Twetman et al., 1995). WSLs were found in 6% (n=11) of 
teeth and there was no difference between test and control group (Twetman 
et al., 1995). Significant differences were found only after one week (p<.01, 
ANOVA) and one month (p<.05, ANOVA) for mutans streptococci.  
Only one study found a significant difference in the long term 
favouring use of GIC after six months (Hallgren et al., 1993), other studies 
found statistically significant differences mainly during the first month 
(Twetman et al., 1995, Wright et al., 1996, Pellegrini et al., 2009, Jose et al., 
2013). 
A chair-side method called rapid adenosine-triphosphate (ATP) - 
driven bioluminescence assay was used to compare plaque bacteria 
adjacent to self-ligating and elastomeric-ligating brackets at one and five 
weeks after bonding in a split-mouth clinical study in n=14 patients. Less 
plaque bacteria were found by the self-ligating brackets and the difference 
was statistically significant (p<.05, paired t-test). The method showed 
excellent correlation coefficients (r) to findings assessed with the gold 
standard by obtaining plaque samples diluted in phosphate buffered saline 
and plated on enriched blood agar (r was 0.895 for total oral bacteria and 
0.843 for total oral streptococci), therefore could be used for future studies 
(Pellegrini et al., 2009). Unfortunately however, no other study has been 
found using the same chair-side method to be able to follow up their 
findings.  
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The most recent clinical study showed significantly lower mutans 
streptococci counts in plaque in 60 patients who used either a probiotic TP 
or curd for 30 days (Jose et al., 2013). 
 
3.12.1.1 Testing saliva 
One study investigated salivary changes and reported only a minor 
improvement in prevention of DMFS. Results cannot justify routine clinical 
use of the tested varnish containing 40% CHX which was compared to a 
placebo varnish and was applied every eight weeks in n=33 subjects during 
their FAOT (median duration 21 months) (Jenatschke et al., 2001).   
 
3.12.1.2 Testing saliva and  plaque 
The effect on both saliva and plaque would provide a more complete 
picture of intraoral changes and the potential to prevent WSLs. The only 
significant decrease for plaque mutans streptococci in a group exposed once 
to F varnish (Fluor Protector 0.7% F-) and Cervitec varnish (1% CHX & 1% 
thymol) during six months of FAOT (p < .01, t-test) occured 12 weeks after 
bonding (Ogaard et al., 1997).  
When a single varnish (Cervitec - 1%CHX & 1% thymol) was 
compared to a placebo varnish, both applied every three months for one 
year in alternate quadrants in n=24 subjects living in a 0.1ppmF area. 
Results showed that the Cervitec group had significantly less DMFS (p< .05, 
Student’s paired t-test) whereas in plaque only mutans streptococci counts 
were significantly less (Madlena et al., 2000). This cross-over design may 
not be the ideal design for such a protocol because there does not seem to 
be a wash-out period between treatments and the duration of the effect of 
treatment is unknown. As a result, there may be an overlap of the effect of 
one treatment over the other.  
Comparing two bonding materials, a GIC (Fuji Ortho) or CR (Concise) 
following one application of 0.4% SnF2 showed no effect in plaque 30 days 
after bonding but a significant reduction of mutans streptococci in saliva 
(p = .638, paired t-test). Results showed that the antimicrobial activity of GIC 
occurred only in the initial phase and had no long-term activity (Mota et al., 
2008).   
With the exception of the self-ligating brackets assessed with a new 
chair-side method (Pellegrini et al., 2009) all other methods tested showed 
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no significant long term decrease in bacterial counts in plaque or saliva. 
More promising results were found when Cervitec was used for six months 
(Hallgren et al., 1993) or a year (Madlena et al., 2000) with significant 
decreases in mutans streptococci occurring but only in plaque. 
 
3.13 Ex-vivo Studies 
3.13.1 Ex-vivo studies investigating arrest of WSLs 
A plaque retaining band was introduced in the 1980’s to promote caries 
formation within four weeks (Arneberg et al., 1984). The first study using this 
band showed 80% reduction in mineral loss when 0.2% NaF rinse was used 
in such lesions examined with MR and micro-densitometry (Ogaard et al., 
1986). The same band was placed in four premolars for up to one month 
with one premolar extracted every week; SEM showed that functional wear 
and TB arrested the lesions by disturbance and removal of bacterial deposits 
rather than incorporation of F (Holmen et al., 1987b). A later study confirmed 
the formation of WSLs within four weeks under SEM examination (Melrose 
et al., 1996). 
The same model was used to compare daily F rinse to combined use of F 
and CHX rinse in n=14 premolars for one month. MR showed significantly 
better results for lesion depth, mineral loss, plaque and saliva counts for 
lactobacillus and streptococcus mutans for the combination group. A 
possible explanation for their findings is that CHX acts on streptococcus 
mutans and has a long lasting effect on plaque acid formation whereas F 
alone cannot repair mineral loss at a very low pH (Ullsfoss et al., 1994).  
The daily use of 0.2% NaF (900ppmF) rinse in five subjects was compared 
to a control group with no intervention, all having banded premolars 
scheduled for extraction after four weeks. MR showed a reduction by 80% 
for mineral loss (p<.05, t-test) and by a factor of 3 for lesion depth, 
highlighting the ability of F to quickly remineralize WSLs in poorly accessible 
areas. However, the small sample size doesn’t provide us with conclusive 
findings (Ogaard et al., 1986).  
Studies used QLF™ and TMR on artificial lesions created on enamel 
specimens with a low ratio of mineral loss to lesion depth, by leaving these 
specimens for two 24h periods in a partially saturated acetic acid solution. 
These lesions further demineralized when brushed twice daily with 
1,100ppm F TP for a month, whereas high ratio lesions showed 
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remineralization. This model showed that there seems to be a dose 
response to F however this needs to be ideally tested on natural WSLs 
(Lippert et al., 2011). 
Formation of WSLs by using an orthodontic band provided a study setting 
that was considered close enough to a real life scenario, enabling 
assessment of the efficacy of various protocols to remineralize i.e. 
arrest/repair/treat WSLs already present in-vivo. These studies show not 
only that TB may have a more important role but also that there seems to be 
a dose response in remineralizing such lesions. F appears to have a key role 
in the process - either as a MW or TP.  
 
3.13.2 Ex-vivo studies investigating prevention of WSLs 
During the 1970’s, some studies followed groups of children throughout their 
FAOT whereas other studies examined WSLs on premolars scheduled for 
extraction and as a result had a shorter duration which ranged from one to 
six or seven weeks (Landry and Shannon, 1973) with the majority lasting for 
four weeks (Ogaard et al., 1986, Holmen et al., 1987a, O'Reilly and 
Featherstone, 1987, Buyukyilmaz et al., 1994, Ullsfoss et al., 1994, Melrose 
et al., 1996, Chung et al., 1998, Czochrowska et al., 1998, Gorton and 
Featherstone, 2003, Pascotto et al., 2004, de Moura et al., 2006, Gontijo et 
al., 2007). A few studies lasted longer; from six to13 weeks (Twetman et al., 
1997), eight weeks (Underwood et al., 1989), three months (Farhadian et al., 
2008) or even six months (Chatzistavrou et al., 2010).  
A frequently quoted study reported that mineral loss assessed by MH and 
localized in an area 50 to 75μm beyond the periphery of the bracket could 
develop in-vivo within four weeks, even if clinically the teeth appear to be 
sound. Prevention was more effective when 0.05% NaF MW was used daily 
in combination with 1,100ppm F TP (O'Reilly and Featherstone, 1987).  
The caries model with bands cemented onto premolars scheduled for 
extraction but leaving 2-3mm of space for plaque accumulation was used in 
20 subjects over a nine week period (Arneberg et al., 1984). QLF™ showed 
that brushing with a 5,000ppm F TP with no rinsing prevented significantly 
more WSLs compared to a control group using 1,450ppm F TP (p <.005, 
unpaired t-test) (Al-Mulla et al., 2010).   
Studies with a single application of F varnish show a significant difference 
(p <.05, Mann-Whitney U test) in lesion depth, mineral loss (Buyukyilmaz et 
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al., 1994) and higher calcium and F content (p <.05, Wilcoxon test) in 
extracted premolars examined with MR and X-Ray spectrometry even in 
subjects living in a fluoridated area (.7ppm F) (Gontijo et al., 2007). A 
number of such studies favoured GIC materials by taking advantage of the 
initial “burst” effect of F release therefore results should be interpreted with 
caution for their long term effectiveness. 
Many studies have found that various GIC products performed significantly 
better compared to different CR products for both lesion depth (p=.024, 
Wilcoxon signed rank test) (Czochrowska et al., 1998) and mineral loss 
(Czochrowska et al., 1998, Gorton and Featherstone, 2003, Pascotto et al., 
2004). WSLs were tested with both MR and MH. Similar results (p=.016, 
Sign test) were found even when WSLs were assessed on photographs by 
one calibrated examiner using a study made index (Chung et al., 1998).  
In the studies with longer duration, the results fail to favour the GIC and 
showed no statistically significant differences from control groups who had 
CR. Two studies investigated bonded premolars scheduled for extraction. 
The first split-mouth study showed no difference (p> .05, Wilcoxon test) 
between GIC (Aqua-Cem, De Tray®) and CR (Concise®) when premolars 
were examined with stereomicroscope after 6-13 weeks (Twetman et al., 
1997). The other split-mouth study testing CR (Transbond XT, 3M Unitek®) 
and GIC (Fuji I GC®), showed after six months higher F- concentrations 
(p <.05, 2-way ANOVA) on premolars bonded with GIC both in the outer and 
deeper enamel surface originating from the cement particles and not ionic 
uptake from the oral environment (Chatzistavrou et al., 2010). One study 
with premolars banded with either GIC or zinc phosphate cement and 
extracted after three months failed to show a statistically significant 
difference (p <.05, Student’s t-test) in the F and Ca++ concentration (Akkaya 
et al., 1996). It appears that the initial “burst” effect of F release from GIC 
materials reaches a plateau in these longer duration studies but at least 
short term GIC used to bond brackets on premolars offers protection against 
WSL. Question remains whether this protection is available long term 
especially since it is not common practice for orthodontists to bond with GIC. 
 
3.13.3 Other methods tested ex-vivo for prevention of WSLs 
Novel protocols preventing WSLs that have been investigated over the years 
include an experimental F-exchanging agent that was compared to CR over 
2 months under PLM. Forty bonded premolars scheduled for extraction in 
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ten subjects were tested. Results showed a 93% reduction (p <.05, ANOVA 
and Student-Newman-Keuls test) of occurrence only for dark zones in the 
test group (Underwood et al., 1989). No follow up study was found on this 
experimental agent.   
A triclosan TP with 1,100ppmF was investigated in a split-mouth study 
where premolars were bonded with plaque accumulating brackets. There  
was  no effect (p >.05, Tukey test) in the RM-GIC group but it performed 
significantly better(p <.05, Tukey test) in the CR group for both depth and 
area of demineralisation (de Moura et al., 2006). No other study was found 
investigating the same TP.   
Significantly harder human enamel was found at 20µm depth when 
premolars were exposed to F elastomers continuously for one month 
(Wilson and Love, 1995). Another study tested a single five minute exposure 
to either CPP-ACP or NaF gel provided statistically significant protection 
against demineralisation (p<.001, Kruskal Wallis rank test) compared to a 
control group after two months in n=21 subjects with no difference between 
test groups. No subjects had any exposure to any other F source for 11 
weeks in total (Uysal et al., 2010a). In a follow up study they compared CR 
with a new CR containing CPP-ACP in n=14 patients. Premolars were 
extracted after 30 days and MH showed statistically significant and 
favourable results for the new material at 10µm distance from the buccal 
enamel surface (p <.001, Tukey post hoc). However, the subjects lived in a 
fluoridated area and didn’t use any extra F for seven weeks (Uysal et al., 
2010b).   
These studies show that F was the main method investigated in various 
ways either alone or incorporated into GIC or combined with other methods. 
It is important to note the overall exposure to F in these studies, as some 
volunteers lived in fluoridated areas but didn’t use any F products during the 
study period. These are situations that do not mimic a real life scenario 
where it would be difficult if not unethical to ask volunteers not to use any F 
products for the duration of the FAOT. 
 
3.13.4 Summary of Ex-vivo studies 
There is a plethora of ex-vivo studies examining premolars scheduled for 
extraction after being exposed to real clinical conditions. The finding that 
WSLs can develop within four weeks even if they are not visible clinically 
dictates the minimum test period for any such protocol (O'Reilly and 
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Featherstone, 1987). Introduction of a plaque retaining band may help 
development of WSLs but it is questionable whether it reflects reality 
(Arneberg et al., 1984). Nevertheless this model has provided valuable 
information especially when testing different bonding materials. However, 
the main critical disadvantage is that the duration of these studies is just a 
fraction of the duration of the FAOT and this factor needs to be taken into 
consideration as short term studies would favour materials which initially 
have an increased F release such as GIC.  
 
3.13.5 Difference between ex-vivo and in-situ studies 
In ex-vivo studies the experiment is done on a tooth in the mouth but the 
measurements are done in the lab. This is a significant difference from 
in-situ studies where the experiment and the measurement are done outside 
of the mouth. Common practice is to attach dental tissue onto a removable 
appliance hosted in the mouth to mimic clinical conditions. 
 
3.14 In-situ studies 
A few in-situ models have been used to test various protocols either to arrest 
WSLs. 
In terms of arresting WSLs  a cross-over study in n=15 subjects who used 
twice daily F TP and once daily F rinse, had a pair of enamel slabs with pre-
formed WSLs placed bilaterally on an arch wire in the lower arch. The 
control slab had an orthodontic bracket attached. After 52 days TMR results 
showed a statistically significant (p=.006, one-way ANOVA) increase in 
remineralisation for the non-bracketed sample (Benson et al., 1999). Time 
was not correlated to any parameters of the lesions. However, this doesn’t 
agree with an earlier study which found an approximately linear relationship 
for bands left in-situ (O'Reilly and Featherstone, 1987). The main difference 
however is that in the recent study the question is not prevention or arrest of 
development of a WSL but regression of a lesion already developed and 
located underneath a bracket.  
 The same model was used in n=12 individuals undergoing FAOT to 
test elastic ligatures with or without F, replaced for an average of 15 times 
during the two experimental periods (6 weeks each) with participants using 
1,055ppmF TP. TMR images were quantified by computerized image 
analysis but results showed no significant difference (p=.0376, one way 
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ANOVA) between the two interventions or the control group (Doherty et al., 
2002). In contrast with their earlier study (Benson et al., 1999) there was a 
trend towards more mineral loss during the study period. This was explained 
as possibly due to the higher mineral loss at baseline (Doherty et al., 2002). 
 A recent in-situ cross-over study compared GIC to F varnish on 
remineralisation of artificial WSLs on human enamel slabs with orthodontic 
brackets bonded on posterior teeth in six volunteers. Results from PLM 
showed a significant difference (p<.05, unknown statistical test) favouring 
GIC possibly due to the initial “burst” effect of F release during the 30 days 
study period (Trairatvorakul et al., 2010). 
In terms of preventing WSLs, bovine enamel blocks have also been used as 
test specimens. Brackets were ligated with elastomeric rings or stainless 
steel wire, placed palatally onto removable appliances dipped eight times 
daily into a 20% sucrose solution. The four volunteers lived in a fluoridated 
area (0.6-0.8 ppm F) and used 1,000ppm F TP for two weeks, three times 
daily. Results of this pilot study showed no difference between the groups in 
their microbiological profile (p >.05, Wilcoxon paired test) and percentage 
mineral volume (p >.05, ANOVA) assessed by cross sectional MH (Gameiro 
et al., 2009).  
It is important to note that some studies (Benson et al., 1999, Gameiro et al., 
2009, Trairatvorakul et al., 2010) have investigated remineralisation of 
already established artificial WSLs hence they investigate arrest/repair of 
WSLs whereas one study investigated prevention of WSLs using bovine 
enamel slabs (Gameiro et al., 2009). 
 
3.15 In-vitro studies 
3.15.1 WSLs investigated on bovine enamel 
Bearing in mind the differences between bovine and human dental enamel 
not only in dental morphology but also in chemical composition, crystal 
structure and physical properties i.e. refractive indices (Yassen et al., 2011), 
results cannot be directly translated into clinical practice. Only one study 
used bonded bovine incisors and light microscopy and image analysis 
showed 38% less mean lesion depth (p <.01, Student’s t-test) for Duraflor® 
F varnish after been exposed to a cariogenic solution for 35 days (Demito et 
al., 2004). 
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3.15.2 Investigating in-vitro enamel sealants in preventing WSLs 
Many in-vitro studies favour use of enamel sealants compared to other 
materials especially in studies with longer duration. The surface area of 
WSLs appears to be directly related to the time premolars are left in 
demineralizing solution and sealant materials appear to offer protection 
(p <.05, Chi-square test) against demineralisation (Hughes et al., 1979). 
These results were confirmed by an identical study from the same group of 
authors (Younis et al., 1979). A highly filled enamel sealant (Pro Seal, 
Reliance, Orthodontic products®) showed statistically significantly less 
demineralisation (p <.05, Newman-Keuls test), compared to etched enamel, 
F varnish application and an unfilled enamel sealant. The enamel specimens 
were tested with micro-hardness (MH), after 14 days of pH-cycling and 
TB(Hu and Featherstone, 2005). The same material and protocol was tested 
with QLF™ and CFLM on premolars showing significantly (p <.05, Kruskal-
Wallis test) less lesion depth (Behnan et al., 2010). “Breaks” have been 
found in sealed slabs when left in a cariogenic solution for 95 hours (Frazier 
et al., 1996). Other in-vitro studies failed to find positive results (p=.621, Chi-
square test) when enamel sealant was applied on the bracket periphery of 
extracted premolars left for 10 days in a demineralizing solution (Farrow et 
al., 2007) or when enamel sealants were compared to a control CR (p <.05) 
(Tecco et al., 2008).  
 
3.15.3 Investigating in-vitro F-releasing materials in preventing WSLs 
The plethora of bonding materials and their proximity to the area where 
WSLs develop have prompted many studies investigating their preventative 
efficiency. Traditional CR materials have been tested (Basdra et al., 1996, 
Vorhies et al., 1998, Todd et al., 1999) alongside GIC (Glasspoole et al., 
2001) and RM-GIC (Schmit et al., 2002, Paschos et al., 2009) which already 
have a good record of studies showing F release hence great potential to 
prevent dental caries. Application of F varnish also enhanced 
remineralization mainly for CR (Kindelan, 1996). Recent studies have also 
tested CCP-ACP® materials i.e. Tooth Mousse (Sudjalim et al., 2007, Uysal 
et al., 2010a). F rinses (225 and 50ppm F) were compared to a placebo 
solution as a daily 5min dipping solution for a period of up to 30 days in 
extracted molars left in demineralising solution for two weeks. Clinical 
photographs were compared with quantitative microradiography and results 
showed that the 50ppm F performed significantly better (Linton, 1996). 
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However all these studies investigated remineralisation of artificially induced 
WSLs hence they do not test prevention but arrest or treatment of WSLs.  
The only study investigating prevention of WSLs showed that bonding 
materials exposed to F varnish (Vanish 3M®) or resin-sealer (Pro-seal, 
Reliance, Orthodontic products®) significantly resisted demineralization 
(p<.05, Kruskal-Wallis test) assessed with QLF™ and CLSM after 15 days of 
pH cycling (Behnan et al., 2010).  
It appears that bonding materials, especially CR, are enhanced by F 
application in preventing WSLs. It is difficult to distinguish between the 
effects of a single F application or of the bonding material especially in 
in-vitro studies with short duration as there is not enough time for the effect 
of the F to be “washed” out. Such studies though provide evidence for 
testing materials in-vivo in clinical trials. 
 
3.15.4 Non-F based preventive regimes for prevention of WSLs tested in-
vitro 
Laser application for 5 seconds resulted in a lower severity index for WSLs 
(Geiger index) on molars bonded with CR compared to visible light curing. In 
the same study there was no difference (p=.055, ANOVA) in surface area 
and lesion depth for WSLs assessed with PLM (Noel et al., 2003).  
The role of different ligation methods was explored on premolars exposed 
for 5 weeks to a cariogenic biofilm model i.e. a cylinder with a two-organism 
(Streptoccocus mutans and Lactobacillus acidophilus) continuous flow 
culture. Even though TMR showed no significant differences (p >.05, 
ANOVA) orthodontic brackets ligated with elastomeric rings tended to 
encourage more demineralisation compared to non-ligated or self-ligating 
counterparts (Amaechi et al., 2006). This highly cariogenic challenge failed 
to find a difference between groups in this short period of time and once 
again, the study could be criticised for not reflecting a more realistic clinical 
time period. 
 
3.15.5 Summary of in-vitro studies 
The in-vitro studies initially used destructive methods such as TMR where 
only a slice of a tooth is examined but more recently, light scattering 
methods such as QLF™ and DIAGNOdent have more frequently been used. 
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However, another problem has now occurred with CR itself generating 
fluorescence.  
Recent studies included pH cycling with/without TB in the test protocol, 
trying to mimic oral conditions. Results seem to favour use of enamel 
sealants; however the risk of breaks within the sealant is always highlighted. 
F releasing materials also seem to perform better compared to CR bonding 
materials whose performance is enhanced by application of F varnishes/gel. 
One study has investigated the role of a solution with a low F concentration 
with promising results.  
None of these short term studies assessed the cost effectiveness of their 
test method in the long term and again, use of clinical subjective indices 
without blinding introduces bias to the study; it is not uncommon to find 
significant differences when subjective clinical indices are used and the 
opposite results when more objective – but maybe destructive methods - are 
employed. 
 
3.16 Testing of bonding materials 
Many studies have tested the efficacy of different materials in preventing 
and/or arresting WSLs. The primary purpose of these materials though is to 
have adequate bond strength to allow bonding of brackets onto human 
dental enamel throughout the course of FAOT. For this reason new 
materials should be tested for both outcomes if planned to serve a dual 
purpose. Comparing argon laser with light curing of a CR bonding material 
showed no significant differences in WSLs changes throughout FAOT, which 
lasted on average 14 months, but the bond failure rate was significantly 
higher in the light curing group (5.7%) compared to the control group (2.4%) 
(Elaut and Wehrbein, 2004). Comparison of two enamel sealants showed no 
difference in bond failure but the chemically cured sealant showed increased 
favourable changes WSLs by 13% (Banks and Richmond, 1994). The only 
study investigating banded first permanent molars showed better results for 
GIC (Ketac-Cem, ESPE®) for band failure whereas there was no significant 
difference in WSLs changes compared to CR (Band-Lok, Reliance®) 
(Gillgrass et al., 2001). When different materials were compared no 
significant differences were found in WSLs changes in any study. Bond 
failures though were significantly higher for cyanoacrylate (Smart Bond) 
compared to a CR (Light Bond®) (Le et al., 2003) and for a RM-GIC (Fuji II 
Ortho LC) compared to a CR (Light Bond Reliance®) (Gaworski et al., 
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1999). No significant difference in bond failure was reported between a CR 
(Rely-a-Bond, Reliance®) and its’ modified version with incorporated F 
(Banks et al., 1997).  
Provided there is adequate bond strength and no difference in bond failure, 
prevention of WSLs was significantly better in only one study (Banks and 
Richmond, 1994) when two enamel sealants were tested. Another study 
reported no difference in bond failures and prevention of WSLs when two 
versions of the same CR were compared (Banks et al., 1997). Even though 
all these split-mouth studies followed subjects throughout the course of 
FAOT no comparisons can be made due to different methodologies.  
Systematic reviews identified use of GIC bonding materials which offer the 
advantage of releasing F- (Derks et al., 2004, Benson et al., 2004). Still one 
of the main problems with GIC bonding materials is poor retention of 
orthodontic brackets (Cook and Youngson, 1988, Cook and Youngson, 
1989, Klockowski et al., 1989, Cook et al., 1996, Ortendahl and Thilander, 
1998). Studies show fairly consistently that CR materials have better bond 
strength both in-vitro and in-vivo (Pickett et al., 2001, Penido et al., 2009) 
compared to GIC (Ortendahl and Thilander, 1998) and/or RM-GIC (Cook et 
al., 1996, Reddy et al., 2003). 
To overcome these problems F-CR materials have been investigated not 
only for their bond strength but for their F release as well. The small quantity 
of measurable F- in a CR, with the Transbond releasing 0.00007 µg/cm2/day 
(Cacciafesta et al., 2007), could be due to the presence of small amounts of 
F- containing glass in its dispersed inorganic phase. It may also be due to a 
constant F- reading being noted in the storage medium e.g. distilled water or 
due to TISAB in the test solution that frees F- bound to hydrogen and is 
recorded by the F- specific electrode (0.1 µg/cm2/six months) (McNeill et al., 
2001).   
Results for F release from F-CR materials in-vitro can be seen in Table 3-3. 
All studies used the F electrode and concluded that no clinical effect is to be 
expected due to small amount of F release, ranging from 0.42ppm (Bishara 
et al., 1991) after 40 days to 212µg after 20 weeks (Chadwick and Gordon, 
1995). 
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Table 3-3 Studies assessing F release from F-CR materials. 
Study Method 
(N=number) 
Materials Duration 
(weeks) 
Storage 
medium 
F release 
from F-CR 
(Fox, 1990) N=10 
specimens 
10x10x1mm 
F-CR Vs 
GIC Vs CR 
20  De-ionised 
water 
Cumulative F 
F-CR=68μg  
(Chan et al., 
1990) 
N=40 human 
molars 
F-CR Vs 
chemically 
cured CR 
6  Water No figures 
given 
(Bishara et al., 
1991) 
N=40 human 
teeth 
F-CR Vs 
chemically 
cured CR 
6  De-ionised Day 
43=0.42ppm 
(Ghani et al., 
1994) 
N=48 
premolars 
Two F-CRs  1 De-
mineralizing 
solution 
 No figures 
given 
(van Rensburg 
and Wiltshire, 
1994) 
N=40 discs Two F-CRs 28 Distilled 
water at 37ºC 
No figures 
given 
(Chadwick 
and Gordon, 
1995) 
N=5/group 
10x10x1mm 
specimens 
RMGIC Vs 
F-CR 
20  De-ionised 
water 
212µg  
(Basdra et al., 
1996) 
N= 5 discs 
5.3x0.8mm 
F-enamel 
sealants Vs 
CR 
12  Distilled 
water 
Plateau within 
14 days  
(.019-.023 
mg/L) 
(Trimpeneers 
and Dermaut, 
1996) 
N=5 discs 
13x1.2mm 
Four F-CR 
Vs GIC 
72  Double-
distilled 
water 
&.1mol/L  
NaCl 
No figures 
given 
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4 Aim of the study 
With regards to prevention of WSLs even though there is a plethora of 
studies available, the systematic reviews that have been published have 
conflicting results and a meta-analysis was not possible due to lack of data. 
Nevertheless the latest four systematic reviews all identified F as playing an 
important role in preventing WSLs but the method of F application has not 
been agreed. It is interesting to note that even though the systematic 
reviews were published from 2001 to 2005 they identified different studies 
that report significant findings. The 2001 review identified F, plaque removal 
by prophylaxis or combined use of NaF and CHX rinse (Bader et al., 2001). 
The Cochrane review identified use of daily F MW (225ppm) or use of GIC 
as a bonding material (Benson et al., 2004). The 2004 review identified use 
of  1,500/5,000ppm F TP, 5,000ppm F gel or use of CHX (Derks et al., 
2004). Another systematic review published in 2005 concluded that topical F 
in addition to use of fluoridated TP, reduced the incidence of WSLs 
commenting that high-potency preparations might offer benefits (Chadwick 
et al., 2005). The latest Cochrane systematic review identified moderate 
evidence favour application of F varnish every six weeks during FAOT 
(Benson et al., 2013) 
The long standing problem of WSLs during FAOT has been investigated for 
many years by in-vitro, in-situ, ex-vivo and in-vivo in clinical trials during the 
course of orthodontic treatment, testing various protocols and applying 
different assessment methods. Initially there was no consensus with regard 
to the scale of the problem with a wide range of prevalence/incidence 
reported (Mitchell, 1992b). It appears that the standard preventive methods 
of using F TP and F MW are not adequate to address the problem with the 
issue of compliance having been frequently highlighted. The scale of the 
need for restorative care appears to be underreported although it is a critical 
outcome following FAOT and an important variable in terms of cost 
effectiveness of any given method to prevent WSLs.  
However, although the methodology is still an issue, there is little doubt that 
F plays a role in preventing WSLs. Bearing in mind that the FAOT may take 
two years or more to be completed, any given method should not only be 
effective in the long-term but ideally would need to be cost-effective as well 
i.e. avoid extra visits or use of costly materials and/or use of auxiliary staff 
that would increase the cost of treatment and/or prolong appointment time. 
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Compliance of the patient is also paramount for any method to be successful 
especially when the patient is a child and/or a young teenager. Bonding 
materials, especially F-CR, could be the answer to these problems since 
they combine anti-cariogenic properties and adequate bond strength. Two 
clinical split-mouth studies followed participants throughout their FAOT for a 
mean period of 21-25 months and support their use (Sonis and Snell, 1989, 
Trimpeneers and Dermaut, 1996).  
For these reasons the aim of this study is to test the FSRGD not only 
because it is a method which has been shown to prevent caries in high 
caries risk children (Toumba and Curzon, 2005) but because it is based on 
long-term and continuous intra-oral release of F, which is the key factor in 
preventing caries and highly relevant to FAOT. It should also prove to be a 
cost-effective method because it is applied once either the introduction of the 
glass bead at the time of bonding and/or incorporation in the CR bonding 
material. Most importantly it does not rely on patient’s compliance and there 
is pilot data to support a clinical trial (Tobin, 2001). 
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5 Objectives of the study 
The objectives were to compare SRFGDs and placebo devices in patients 
scheduled to have FAOT in a randomised, double-blind, controlled clinical 
trial. Buccal surfaces of the upper six anterior teeth (upper central, lateral 
incisors and canines) were examined with quantitative light fluorescence 
(QLF™) and with cross-polarising digital photographs analysed with image 
analysis software - Adobe Photoshop® (Adobe Systems Inc., California, 
USA). Photographs were taken on the day when fixed appliances were 
placed and following removal of fixed appliances and bonding material.      
An exploratory study will investigate the F and PO4 release of a composite 
resin material enriched with SRFGDs in the form of powder. The potential of 
caries prevention effect from F release of a bonding material needs to be 
investigated against the ability to display sufficient bond strength for 
orthodontic brackets to adhere to tooth enamel.  
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6 Null Hypotheses 
There is no difference in the incidence of WSLs in patients having SRFGDs 
compared to a placebo device, during their course of FAOT on the upper 
anterior teeth.   
There is no difference in the severity of WSLs as assessed by the number of 
teeth with WSL(s) on each participant having SRFGDs compared to a 
placebo device, during their course of FAOT on the upper anterior teeth. 
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7 Materials and Methods 
7.1 Materials 
The following materials were used: 
Test materials were prepared using moulds as described by (Musanje et al., 
2001) in order to allow fabrication of specimens that comply with British 
Standard BS EN ISO 9917-1:2007. Bar specimens (26 X 1.5 X 1.0 mm3) of 
each material were fabricated in the mould made from poly-tetra-fluoro-
ethene (PTFE) as seen in the following figure (Figure 7-1).  
 
Figure 7-1 Diagram and pictures of PTFE mould. From Musanje et al., 
2001. 
 
 
 
 
 
 
 
 
 
Composite resin for bonding of orthodontic brackets (Transbond, 3M®) 
Grinding of SRFGD glass (containing sodium 21.2%, phosphorus 20.7%, 
aluminium 6.8%, fluorine 19.5% and oxygen 31.9%) to powder of various 
particle sizes with steel dish (Gyro Mill) and fractionated using sieve stacks 
(30μm).  
Composition of AS used as a storage medium (Leung, 1991) is seen in the 
following table (Table 7-1).  
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Table 7-1 Composition of AS used as a storage medium. 
 /g dm -3 Moldm -3  
Stock Solution A 
NaH2PO4 28.0 0.2333 
KCl 86.8 1.164 
NaCl 7.21 0.123 
NH4Cl 11.0 0.205 
Trisodium citrate 2H2O 1.1 3.74 X 10 -3 
Lactic acid 3.5 0.039 
Stock Solution B 
Urea 10.0 0.167 
Uric acid 0.75 4.46 X 10 -3 
NaOH 0.2 5.00 X 10 -3 
Stock Solution C 
KSCN 12.0 0.123 
 
A Fuji S3 Pro Fine Pic Macro Lense with a Sigma ring flash and cross 
polarising filter. To operate the camera F11 was used at 1:25 of the second 
and 1:4 ring flash speed.  
Digital photographs were uploaded to a computer and analysed using the 
Adobe Photoshop Software (Adobe Systems Inc California, USA).   
SRFGDs and a prototype plastic holder manufactured by Ultradent®1. 
Ion Chromatography (761 Compact, Metrohm RP) seen in Figure 7-2 was 
used to assess ion release. For the suppressed analysis the Hamilton PRP x 
110S 7um 250X4.1mm column with the Metrohm RP Guard column was 
selected for analysing the F and PO4 anion with a carbonate eluent (NaHCO3 
1.7 mmol/l and Na2CO3 1.8 mmol/l) at 0.5ml/min flow rate. The y axis presents 
conductivity (uS/cm) and the x axis retention time (min). Note the F peak 
obtained at 9.3 min. 
                                            
1Ultradent Products Inc., Utah, USA. 
59 
 
Figure 7-2 Ion chromatography and chromatogram demonstrating the F 
peak in a standard 1ppm F solution sample.  
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7.2 SRFGDs with plastic holder 
The initial design provided by the manufacturer had a hole on one side for 
the orthodontic wire to be threaded as seen in Figure 7-3. When tested in 
the mouth the holder was lying above the occlusal plane thus interfering with 
the occlusion. The holder was tested in the lower arch as seen in but it was 
still interfering with the occlusion  as seen in Figure 7-4. An adjustment was 
made and a metallic tube was attached on the posterior side of the plastic 
holder. Following this modification, the device was at the same level as the 
orthodontic brackets as seen in Figure 7-5. This meant it no longer interfered 
with the occlusion and was also unable to rotate around the orthodontic wire 
hence improving necessary retention and stability in the mouth in order to 
minimise the risk of breakage and/or loss of the device. The new design was 
discussed with the manufacturer and was adopted to provide a plastic holder 
with a hole on the posterior side as seen in to improve retention and avoid 
occlusal interference as seen in Figure 7-6 and Figure 7-7.  
Figure 7-3 Initial design of the plastic holder with the SRFGDs. 
   
 
Figure 7-4 Clinical view of the holder with SRFGD placed in the lower 
arch. 
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Figure 7-5 Clinical view of the holder with SRFGD placed in the upper 
arch after adhesion of metallic tube on the plastic holder. 
 
.  
 
Figure 7-6 Final design of holder as provided by the manufacturer. 
  
 
Figure 7-7 Clinical view of the holder with SRFGD onto the orthodontic 
wire. 
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7.3 Methods of investigation 
This section will cover the following: 
 In-vitro exploratory study 
 Questionnaire to orthodontist-members of the British Orthodontic 
Society (BOS) 
 Socio-economic status (SES) of eligible participants in clinical study 
 Clinical study 
 
7.4 In-vitro exploratory study 
7.4.1 Steps of the in-vitro study 
Five different liquid storage mediums were assessed for their F- and PO4 
release using IC.  
 
SRFGDs were ground into powder and sieve stacks were used in order to 
obtain powder with a known particle size.  
 
Since solubility is affected by surface area, SRFGD with a given weight was 
compared to the same weight of powder with different particle sizes in order 
to obtain similar F- and PO4 release to the SRFGD used as a control. Ion 
chromatography was used to measure concentration of F- and (PO4)
---.  
 
Morphology of powder with particle size that exhibited similar solubility to 
SFRGD was assessed using SEM.   
 
In order to explore F- and PO4 release different types of powder were mixed 
with the control material (Transbond®) at different ratios, giving 40 different 
combinations as seen in Table 7-2. All 40 samples were prepared using 
PTFE mould and stored in AS.    
 
Transbond® was hand mixed with powder using spatula on a glass pad. The 
test material was placed in PTFE mould and covered with glass before been 
light cured.    
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Table 7-2 Different types of powder mixed with Transbond at different ratios. 
 Solubility 1 Solubility 3 Solubility 16 Solubility 50 
Ratio 1:6 *<38µm >38µm <38µm >38µm <38µm >38µm <38µm >38µm 
Ratio 1:7  <38µm >38µm <38µm >38µm <38µm >38µm <38µm >38µm 
Ratio 1:8 <38µm >38µm <38µm >38µm <38µm >38µm <38µm >38µm 
Ratio 1:9 <38µm >38µm <38µm >38µm <38µm >38µm <38µm >38µm 
Ratio 
1:10 
<38µm >38µm <38µm >38µm <38µm >38µm <38µm >38µm 
*particle size of <38µm or >38µm 
 
Universal Testing Machine (UTM) (Lloyd LR10K) was used to test flexural 
modulus of elasticity and flexular stress of samples prepared in a PTFE 
mould to comply with British Standards EN ISO 9917-1:2007. These two 
measurements will allow assessment of the debonding force at a cross-head 
speed of .1mm/min and load cell of 20N. Depending on the surface area of 
the sample the debonding strength of the test material would be estimated.  
 
For the purpose of the in-vitro study, AS was used as a storage medium in 
order to create an environment for the specimens close to intra-oral 
conditions (Leung and Darvell, 1997). The composition of AS used in this 
study is seen in Table 7-1 and was originally developed by (Darvell, 1978) 
based on human saliva analysis and improved by adding potassium (Leung, 
1991). It has been extensively used in studies looking into mechanical 
behaviour of dental materials including glass-ionomer (Musanje et al., 2001, 
Musanie and Darvell, 2003, Musanie and Darvell, 2004). 
 
Determination of phosphate shows degradation of the glass bead as it is the 
core ion of the glass. Test specimens and control specimens of the material 
were assessed to compare concentration for these ions. Ion 
Chromatography is considered the method of choice for analytical 
determination of free ions (Fritz, 2004). Two studies in dental research have 
used ion chromatography for the determination of F- in distilled or de-ionised 
water from dental materials in-vitro (McCabe et al., 2002, Itota et al., 2004). 
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7.5 Questionnaire to specialist orthodontist - members of the British 
Orthodontic Society. 
A questionnaire was emailed to all specialists orthodontist members of the 
British Orthodontic Society (www.bos.org.uk) to screen current clinical 
practice. The questionnaire can be found in the appendix (Appendix No 14). 
 
7.6 Socio-Economic Status (SES) of eligible participants in clinical study 
The address/postcode of the eligible participants was used to identify their 
Multiple Deprivation Index (MDI) (McCabe et al., 2002) in order to identify 
significant differences between volunteers and those who declined 
participation.  
 
7.7 Clinical study 
 
7.7.1 Study setting 
The study took place in the Orthodontic Department at the Leeds Dental 
Institute, in Leeds, West Yorkshire, U.K. and the author (CT) was 
responsible as the principal investigator for identification, recruitment, 
obtaining consent and follow-up of the participants according to the study 
protocol. 
 
7.7.2 Study design 
The study design was a prospective, randomised, controlled and double-
blind clinical trial using test and placebo devices with a follow-up period of at 
least one year. The treatment /intervention was placement of SRFGDs. 
 
7.7.3 Ethics Committee Approval of the clinical study 
Approval from Leeds Central Research Ethics Committee, Leeds, UK was 
obtained for this study on 29/04/2008, Reference Number 08/H1313/6. An 
amendment of the protocol was also reviewed and approved by the same 
Research Ethics Committee on 10/6/2008. The amendment was an 
additional examination of teeth for signs of WLSs with a method called 
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“quantitative light-induced fluorescence” or “QLF™”, which is based on the 
auto-fluorescence of teeth. Approval from Research and Development Office 
at the Leeds General Infirmary, Leeds, West Yorkshire, U.K. was also 
obtained on 15/05/2008, Reference Number DT08/8473. The relevant 
documentation can be found in the appendix (Appendix No 1,2). Following 
ethical approval all clinicians in the orthodontic department at the Leeds 
Dental Institute were informed about the study via email; the protocol of the 
study was circulated and comments and questions were welcomed. Each 
clinician was contacted personally by email to establish whether patients 
routinely have any F application prior to FAOT; to identify at which stage the 
orthodontic brackets were removed in relation to their retention phase of 
treatment and by whom and when the bonding material was removed. This 
information was important because it provided a better insight into how 
clinicians work; it assessed the F exposure and confirmed the homogeneity 
of the study sample. In total, 23 members of staff were contacted; 12 
consultants, seven senior specialist registrars and four specialist registrars. 
 
7.7.4 Outcome variables 
The primary outcome was: the incidence of WSLs on the buccal surfaces of 
the six upper anterior permanent teeth. Presence/absence of early enamel 
lesions was defined by visual examination of digital photographs and clinical 
examination. The type of variable: nominal.  
 
The secondary outcome was: severity of WSLs on the buccal surfaces of six 
upper anterior permanent teeth. The surface area of the WSLs was drawn 
and expressed as a percentage of the total buccal tooth area using a 
computer software package to analyse digital photographs. The type of 
variable: metric continuous.  
 
Satisfaction questionnaires were given to the participants and the 
orthodontists responsible for the FAOT of the participants at the last 
appointment for their FAOT. This documentation can also be found in the 
appendix (Appendix No 11,12). Type of variable: nominal. 
 
Loss and/or breakage of the device were documented in the CRF form by 
the responsible clinician orthodontist. Type of variable: nominal.  
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In order to account for any confounding factors as identified in the literature 
the following data were collected: age, gender, address/postcode, DMFS/T, 
dmfs/t, duration of orthodontic treatment, Plaque Index (PI) and Gingival 
Index (GI).  
 
7.7.5 Inclusion criteria 
The eligible participants had to meet the following inclusion criteria: 
 Volunteers could be included up to 18 years of age at the start of the 
study. 
 Volunteers should have no relevant medical history and should not be 
under any regular medication that was known to affect the oral cavity 
and oral flora status.  
 Volunteers should have given consent to have FAOT.  
 Volunteers should not be pregnant.  
 The following permanent teeth had to be present in the upper dental 
arch: incisors and/or canines.  
 Valid (informed) consent obtained from parent(s)/legal guardian(s) 
using a consent form approved by the Ethics Committee. All 
participants were below 18 years of age at the start of the study and 
were encouraged to sign, should they wish to do so, a consent form 
approved by the Ethics Committee. 
 Exposed to water F levels of <.1 ppm F, considered to be the limit 
below which there is no protective effect against dental caries (ten 
Cate, 2001), in order to minimise any systemic exposure to F in the 
drinking water. This was established by contacting the local water 
provider - Yorkshire Water (http://www.yorkshirewater.com) and the 
British Fluoridation Society (http://www.bfsweb.org/index.htm). 
 Willing to refrain from using any additional F products during the 
period of the study, other than standard adult F toothpaste 
(1,100-1,450ppm F) and F mouth-rinse (225 ppmF) but maintaining 
normal dietary habits. 
 
7.7.6 Exclusion criteria 
Volunteers were excluded if any of the following applied: 
 Volunteers who were older than 18 years of age at the start of the 
study. 
 Volunteers with a relevant medical history and/or under regular 
medication known to affect the oral cavity and oral flora status.  
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 Volunteers who had not given consent to have FAOT.  
 Pregnant female volunteers.  
 The following permanent teeth were not present in the upper dental 
arch: incisors and/or canines.  
 Exposed to water F levels of >.1 ppmF, considered to be the limit 
above which there is a protective effect against dental caries (ten 
Cate, 2001), hence it would be impossible to differentiate whether 
protection (if any) against development of WSLs would have resulted 
from the devices or exposure to F in the drinking water.    
 A signed, valid (informed) consent form was not obtained from the 
parent(s)/legal guardian(s) and/or participants. 
 
7.7.7 Sample size 
The level of significance for the study was set to .05 (α=0.05) and the power 
of the study to 90% (1–β=.90). The number of participants was established 
by analysing data from previous, related studies (Artun and Brobakken, 
1986, Ogaard, 1989) and a pilot study (Tobin, 2001) and using this data to 
support a formal sample size calculation formulated with the assistance and 
guidance of Mr Andrew Blance, Lecturer in Statistics and Mrs Theresa 
Munyombwe Lecturer in Biostatistics, Centre of Epidemiology and 
Biostatistics, Faculty of Medicine, University of Leeds, Leeds, West 
Yorkshire, U.K. These statisticians also provided guidance and assistance 
for the statistical analysis of this research project. 
 
The sample size calculation was based on the primary outcome i.e. 
incidence of WSLs by assessing previous studies with related research 
questions. The first stage of the sample size calculation treated observations 
as independent and in the second stage accounted for clustering. The 
following steps were undertaken for the sample size calculation: 
 
The clinically relevant significant difference was a 10% reduction in the 
number of teeth with WSLs. 
 
We assessed available data for the six (6) teeth to be examined in this study 
and/or incidence of WSLs in teeth overall. 
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The sample size calculation was based on the difference in proportions in 
treatment and control groups assuming our observations were independent.  
The reference table 3.1 page 40 and equation 3.7 page 21, Chapter 3 were 
used from “Sample size tables for clinical studies” (Machin et al., 1997). The 
power was set at 90%; 1−beta=.90 and alpha (2−sided)=.05.  
 
Since 6 teeth per subject were examined therefore our observations were 
not independent, we needed to account for the effect of clustering using the 
design effect i.e. to establish what increase in the sample size was required 
to account for the natural association between the teeth within the same 
individual. Data on a single tooth per individual would provide us with 
information only for this particular tooth. As there is no single tooth most 
commonly affected by WSLs during FAOT this approach allows us to 
investigate more teeth in fewer individuals but still taking into account the 
effect of clustering and increasing the sample size as appropriate 
(Thompson et al., 2012). 
 
Design effect=1+(m–1) x ICC, where m is the size of our cluster (m=6) and 
ICC (intra class correlation coefficient) is an estimate of the variation 
attributable to the cluster, as a proportion of the total variation, set to be 
quite small at .04.  
 
Deff=1 + (m – 1) x ICC = 1 + (6-1) x ICC = 1 + 5 x 0.04 = 1 + 0.2 = 1.2 
 
The final calculation step was as follows: 
Sample size=Sample size from tablesX1.2(design effect)/6(size of cluster). 
The older study published in 1986 (Artun and Brobakken, 1986) was used as 
it had adequate follow up (1-1.8 years) and an adequate number of 
participants (180 subjects).   
The percentage of teeth with WSLs in the corresponding groups was 5% 
and 16.9%.    
Based on the findings from this study the sample size was estimated 
following the previously stated steps:  
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Stage one: 
 
 
 
 
  
m=[1.96√{(2x0.1095)1-0.1095)}+1.2816√{0.05(1-0.05)+0.169(1-
0.169)}]2/0.1192 
m=[1.96√{(2x0.1095x0.8905)}+1.2816√{(0.05x0.95)+(0.169x0.831)}]2 
/0.014161 
m= [1.96 √ 0.1950195 + 1.2816 √ (0.0475 + 0.140439)] 2 / 0.014161 
m= [1.96 x 0.4416101 + 1.2816 √ 0.187939] 2 / 0.014161 
m= [0.8655557 + 1.2816 x 0.4335193] 2 / 0.014161 
m= [0.8655557 + 0.5555983] 2 / 0.014161 
m= [1.421154] 2 / 0.014161 = 2.0196786 / 0.014161 = 142.62259 
 
m=143 subjects per group 
 
 
m = [Z 1-a √ {(2π (1- π))} + Z 1-b √ {π1 (1- π1) + (π2 (1- π2)}] 
2 / δ 2 
 
m =sample size  
Z 1-a =1.96  
π1 = 0.05 = success under treatment  
π2 =  0.169 = success under placebo  
π = π1 + π2  / 2 = 0.05 + 0.169 / 2 = 0.1095  
Z 1-b = 1.2816 
δ = 0.169 – 0.05 = 0.119=anticipated increased proportion of successes 
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Stage two: 
A sample size calculation was also undertaken for the secondary outcome 
based on the pilot work (Tobin, 2001) for the severity of WSLs by comparing 
means and using tables from the above mentioned reference and equations 
to compare means of independent groups. Based on the findings from this 
study the sample size was: 
 
 
 
The risk of patients failing to complete their orthodontic treatment has been 
reported in the dental literature. Two hospital based studies which together 
investigated over 700 patients, reported rates of 17.6–19.5% over a four 
year period (Roberts et al., 1994, Trenouth, 2003). Based on these figures 
the number of participants was increased from 29 per group. 
 
 
 
  
29 + 18%  =  34.22 
29 + 20%  = 34.80 
Sample size = 
Sample size from tables x 1.2 (design effect) / 6 (size of cluster) 
Sample size = 143 x 1.2 / 6 = 29 subjects/group 
n = (2 x SD2 x magic number / difference in means2 ) +1 
Magic number is 10.5 for alpha =.05 and power 90%; 1- beta=.90 
Based on the above equation and use of tables the sample size was 
n=26 subjects/group 
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7.7.8 Allocation-Randomisation process 
Randomisation of participants into two groups with equal allocation was 
carried out by a statistician using S-Plus programme and 5984 random seed 
to provide a random number generated list. The code could be accessed by 
two supervisors only. The statistician provided us with a random list of 
numbers produced by a random number generator with equal allocation of 
participants based on their gender to placebo/treatment. A printed list was 
also available in clinic stating whether the volunteer was allocated to group A 
or B according to their gender and in numerical order e.g. first female 
allocated to group A. The principal investigator, the clinician orthodontists, 
the participants and the members of staff on clinic were blinded whether 
group A corresponded to treatment or placebo. The codes were kept in a 
sealed envelope in the office of two supervisors and in the master file and 
were revealed at the end of the study. Glass beads were kept in two 
separate plastic boxes named A or B by the responsible supervisors. 
 
7.7.9 Steps of the clinical study 
Potential participants were identified through the computerised appointment 
booking system. 
Information sheet for parents and potential participants were posted together 
with an invitation letter for participation in the study separately to their 
appointment letter. The documentation can be found in the appendix 
(Appendix No 4,5,6,7). 
Potential participants, who expressed an interest in participating in the 
research study, when they attended for their scheduled orthodontic 
appointment, had a dental clinical examination to record their dental status 
and to assess if they fulfilled the inclusion criteria. On the day of the dental 
examination, the consent forms and the parent’s and patient’s information 
sheet were available for any questions to be answered and the potential 
participant together with their parent(s)/legal guardian(s) were given time 
until their next scheduled appointment for orthodontic treatment to decide on 
their participation in the study. A letter was to be posted to the volunteer’s 
General Dental Practitioner. The documentation can be found in the 
appendix (Appendix No 8).  
For each participant, cross-polarising digital photographs were taken on the 
day of placement of the fixed appliances and SRFGDs and following 
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completion of FAOT and on the day of removal of fixed appliances and 
bonding material. The SRFGDs rested in a plastic holder threaded onto the 
orthodontic wire and placed by the clinician orthodontist anterior to the last 
banded molar and posterior to the adjacent tooth (e.g. between 16 – 15 and 
26 - 25, FDI notation).  
The Case Record Form (CRF) of the participants was filled in to document 
any adverse event and to collect all relevant documentation for participants. 
All Case Record Forms together with the Master File of the research study 
with all relevant documents were kept on clinic in a location known to staff 
members of the Orthodontic Department. The documentation can be found 
in the appendix (Appendix No10). 
 
7.7.10 Data collection and management 
The following data were collected from the patient’s dental notes in order to 
account for possible confounding factors for development of WSLs: age, 
gender, address/postcode, DMFS/T, dmfs/t, duration of FAOT, PI and GI.  
Satisfaction questionnaires for participants and orthodontists were provided 
at the end of the study. It was piloted amongst members of staff before 
finalized and it can be found in the appendix (Appendix No11,12).   
Loss and/or breakage of the device were documented in the CRF form by 
the responsible clinician orthodontist.  
Three digital photographs were taken; one from the maxillary right canine 
and lateral incisor, one from the maxillary central incisors and one from the 
maxillary left lateral incisor and canine. The cross-polarising technique was 
used (Robertson and Toumba, 1999) with the same equipment and under 
the same conditions by photographers at the photography department at the 
Leeds Dental Institute, Leeds, UK. The photographers and the principal 
investigator were calibrated against each other by examining a photograph 
of artificial WSL on a tooth, using the same equipment on a premolar tooth 
with an artificial WSL on the buccal surface used as a prototype.  
Presence/absence of WSLs was determined on the digital photographs 
loaded onto a computer. One examiner performed all assessments to 
improve the reproducibility of the procedure. Cohen Kappa scores were 
obtained by randomly re-examining 10% of the sample. 
Presence/absence of WSLs was determined clinically using a hand-held 
QLF™. One examiner performed all assessments to improve reproducibility 
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of the procedure. Cohen Kappa scores were obtained by randomly re-
examining 10% of the sample. 
Severity of WSLs was determined by measuring the surface area of the 
lesion using Adobe Photoshop® Software (Adobe Systems Inc California, 
USA). The digital images were saved as JPEGs (Joint Photographic Experts 
Group) files. The computer monitor screen resolution was set at 1920 x 1200 
and colour resolution at 32-bit true colour. The outline of the buccal surface 
of the teeth was drawn freehand using the magnetic lasso tool and was 
cropped of gingival tissue and surrounding teeth and stored as a new JPEG 
image as seen in Figure 7-8. A unique code number was given prior to 
analysis (Kanthathas et al., 2005a).  
  
74 
 
Figure 7-8 Tooth outline with arrow denoting the WSL. 
 
The number of pixels within the WSL and the buccal surface were recorded 
as seen in Figure 7-9. WSL area was defined as a percentage of the total 
labial surface i.e. WSL% = (Area of the lesion / Area of the tooth) x 100 
following the method used in a previous study (Kanthathas et al., 2005a). 
One examiner performed all the assessments in order to improve the 
reproducibility of the procedure. Cohen Kappa scores were obtained by re-
examining 10% of the sample. 
Figure 7-9 Tooth area and WSL area outline with arrow denoting the 
WSL. 
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WSL area was defined using the count tool to place marks freehand on the 
borders of the lesion as seen in Figure 7-10 and Figure 7-11. 
. 
Figure 7-10 Marks of WSL drawn freehand. 
 
 
Figure 7-11 Outline of WSL drawn freehand. 
 
 
In order to reduce the subjective nature of freehand placement of marks to 
define WSLs, the following steps were taken; the mean grey value in healthy 
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enamel as seen in Figure 7-12 and in a representative area within the WSL 
were measured using the elliptical marquee tool as seen in Figure 7-13.  
 
Figure 7-12 Mean grey value (174) in a representative area of healthy 
enamel denoted by arrow. 
 
 
Figure 7-13 Mean grey value (194) in a representative area within the 
WSL denoted by arrow. 
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The mean grey value ranged from 0 representing black to 255 representing 
white. The mean of the difference in the grey value between healthy enamel 
and WSL was added to the grey value of the healthy enamel. This value was 
used as a reference point to outline the periphery of the WSLs i.e. 
WSL = [(Lesion – Healthy) / 2] + Healthy 
     For example:     WSL = [(194 – 174) / 2] + 174 
                                WSL = (20 / 2) + 174 
                                WSL = 10 + 174 = 184 
                                WSL = 184 
The mean grey value of the free hand placed marks was measured using 
the rectangular marquee tool to a pixel level as seen in Figure 7-14 and was 
compared with the reference value. 
 
Figure 7-14 The mean grey value of each hand placed mark was 
measured to a pixel level denoted by arrows. 
 
 
Using the count tool the freehand placed marks were moved accordingly and 
re-measured to a pixel level until their mean grey value met the reference 
value on the borders of the WSLs to provide the final outline of the WSL as 
seen in Figure 7-15 and Figure 7-16. 
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Figure 7-15 Initial outline of WSL following placement of hand placed 
marks to a pixel with a corresponding mean grey value of 184. 
 
 
Figure 7-16 Final outline of WSL following placement of hand placed 
marks to a pixel with a corresponding mean grey value of 184. 
 
 
The surface area within the corrected outline of the WSL was measured as 
number of pixels and expressed as a percentage of the total tooth surface 
area. To minimise human error the marks placed freehand to define the 
WSLs were defined by their mean grey value. The mean grey value of the 
difference between healthy enamel and WSLs was used as the cut-off point 
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to mark the WSLs. It appears from the photos that a significant area of WSL 
is “excluded” in the final outline but this is a systematic and reproducible 
method of defining WSLs.  
 
7.7.11 Statistical Analysis 
For descriptive statistics and functional data statistical analysis the IBM 
SPSS Statistics 22® software package was used2. Zero inflated Poisson 
regression was applied to model the effect of all variables on number of 
teeth with WSL. All statistically significant variables at p1=0,20 were entered 
in the initial model and the results were compared to those of the simple 
Poisson regression model with the use of the vuong test and model fit was 
assessed as significantly better as 44 individuals showed no WSL (zero 
counts) at the end of the study. Model fit was assessed with the use of 
Akaike's information criterion and Bayesian information criterion. Variables 
were considered as statistically significant at p<.05. Analysis was carried out 
using STATA® v.13.03 
                                            
2IBM SPSS Statistics 22, IBM Corporation, New York, USA. 
3Stata v13, StataCorp LP, Texas, USA. 
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8 Results 
8.1 In-vitro exploratory study 
 
8.1.1 Storage mediums 
Firstly various storage mediums were assessed for their F and PO4 release 
over two weeks. These were AS and water either distilled, deionised, tap or 
sterile; the results can be seen in Figure 8-1 and Figure 8-2 and the 
standards used in Table 8-1 and Table 8-2.  
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Figure 8-1 F release from different types of storage medium over n=14 days. 
 
AS=artificial saliva, n=number 
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Table 8-1 F standards for different types of storage mediums. 
Fstandard 
(ppm) 
3 0.3 0.03 0.003 
1
st
 measurement 3.01 0.29 0.03 0.002 
2
nd
 measurement 2.88 0.31 0.02 0.003 
3
rd
 measurement 2.96 0.28 0.03 0.004 
Mean ± SD 2.95±0.06 0.29±0.01 0.02±0.005 0.003±0.001 
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Figure 8-2 PO4 release from different types of storage medium over n=14 days. 
 
AS=artificial saliva, n=number 
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Table 8-2 PO4 standards used for different types of storage mediums. 
PO4 standard (ppm) 500 250 100 
1
st
 measurement 495.34 238.27 97.82 
2
nd
 measurement 498.94 244.92 102.07 
3
rd
 measurement 501.24 248.55 99.44 
Mean ± SD 498.51 ± 2.98 243.91 ± 5.21 99.77 ± 2.15 
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8.1.2 Control material 
The control material Transbond® was also tested for F and PO4 release. 
The F and PO4 standards are seen in Table 8-3 and Table 8-4 alongside the 
results seen in Figure 8-3 and Figure 8-4. 
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Figure 8-3 F release from control material (Transbond®) over 28 days. 
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Table 8-3 F standards for Transbond®. 
F standard 
(ppm) 
3 0.3 0.03 0.003 
1st measurement 3.01 0.28 0.03 0.002 
2nd measurement 2.98 0.28 0.029 0.004 
3
rd
 measurement 2.97 0.27 0.032 0.003 
Mean ± SD 2.99±0.02 0.28±0.01 0.03±0.00 0.003±0.001 
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Figure 8-4 PO4 release from control material (Transbond®) over 28 days. 
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Table 8-4 PO4 standards used for Transbond®. 
PO4 standard (ppm) 500 250 100 
1st measurement 498.25 240.24 98.55 
2nd measurement 496.54 246.85 103.21 
3rd measurement 500.15 252.05 99.75 
Mean ± SD 498.32  ± 1.80 246.38  ± 5.92 100.51  ± 2.42 
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8.1.3 Assessment of powder particle size with scanning electron 
microscopy (SEM). 
SRFGDs with different solubility (relative scales of 1, 3, 16 and 50) were 
changed into a powder form and fractionated using sieve stacks (30µm) 
producing a powder with a particle size of 38µm. The particle size was 
confirmed using SEM seen in Figure 8-5.  
 
Figure 8-5 SEM images of powder from SRFGDs with relative solubility 
3. 
   
Particle size: >38 µm    
  
Particle size: <38 µm   
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8.1.4 F and PO4 release from powder from SRFGDs 
Powder from SRFGDs with different particle sizes was assessed with IC for 
F and PO4 release. The results can be seen in Figure 8-6 and Figure 8-7. 
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Figure 8-6 F release from powder from SRFGDs with different solubility and particle size, in AS after two months. 
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Figure 8-7 PO4 release from powder from SRFGDs with different solubility and particle size, in AS after two months. 
 
 
 
Sol = relative solubility, n=5 
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8.1.5 F release from powder mixed with control material 
Powder from SRFGDs with different particle size and different solubility was 
mixed with the control material (Transbond®), giving 40 different 
combinations with one sample per combination. F release was assessed 
with IC at two weeks, four and six months. The results are seen in the Figure 
8-8, Figure 8-9 and Figure 8-10. 
 
Samples were left in 2ml of AS and after two weeks 200µl was analysed with 
IC. The findings as seen in Figure 8-8 show that the powder with the 
maximum F release (220.07 ppmF) had solubility of 16, ratio of powder to 
Transbond® 1:6 and particle size of more than 38µm.  
 
The findings after four months as seen in Figure 8-9 show that the powder 
with the maximum F release (65.29 ppmF) had solubility of 16, ratio of 
powder to Transbond® 1:6 and particle size of less than 38µm.   
 
The findings after six months as seen in Figure 8-10 show that the powder 
with the maximum F release (101.45ppmF) had solubility of 16, ratio of 
powder to Transbond® 1:8 and particle size of less than 38µm. A summary 
of the findings is seen in Table 8-5. 
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Figure 8-8 F release in AS after two weeks after mixing Transbond® with powder from SRFGDs.  
.  
Ratio = ratio of powder to Tranbsond®, AS= artificial saliva, TB = Transbond®, F release for AS and TB is zero therefore not shown on graph 
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Figure 8-9 F release in AS after four months after mixing Transbond® with powder from SRFGDs. 
 
Ratio = ratio of powder to Tranbsond®, AS= artificial saliva, TB = Transbond®, F release for AS and TB is zero therefore not shown on graph 
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Figure 8-10 F release in AS after six months after mixing Transbond® with powder from SRFGDs. 
 
Ratio = ratio of powder to Tranbsond®, AS= artificial saliva, TB = Transbond®, F release for AS and TB is zero therefore not shown on graph 
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8.1.6 PO4 release from powder mixed with control material 
PO4 release was also assessed with IC for 40 combinations with one sample 
per combination at two weeks, four and six months. The results are seen in 
Figure 8-11, Figure 8-12 and Figure 8-13.  
 
Samples were left in 2ml of AS and after two weeks 200µl was analysed with 
IC. The powder with the lowest PO4 release (141.87 ppmPO4) as seen in 
Figure 8-11 had solubility of 3, ratio of powder to Transbond® 1:10 and 
particle size of more than 38µm.  
 
The powder with the lowest PO4 release (55.52 ppmPO4) after four months 
as seen in Figure 8-12 had solubility of 50, ratio of powder to Transbond® 
1:10 and particle size of less than 38µm.    
 
The powder with the lowest PO4 release (75.51ppmPO4) after six months as 
seen in Figure 8-13 had solubility of 1, ratio of powder to Transbond® 1:8 
and particle size of less than 38µm. A summary of the findings is seen in 
Table 8-5. 
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Figure 8-11 PO4 release in AS after two weeks after mixing Transbond® with powder from SRFGDs. 
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Figure 8-12 PO4 release in AS after four months after mixing Transbond® with powder from SRFGDs. 
 
Ratio = ratio of powder to Transbond®, AS = artificial saliva, TB = Transbond® 
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Figure 8-13 PO4 release in AS after six months after mixing Transbond® with powder from SRFGDs. 
 
Ratio = ratio of powder to Transbond®, AS = artificial saliva, TB = Transbond® 
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A summary of the findings is seen in the following table. 
Table 8-5 Summary of findings for F and PO4 release after two weeks, 
four and six months. 
  Highest F (ppm) Lowest PO4 (ppm) 
Six months Release 101.45 75.51 
 Solubility 16   1 
 Ratio powder: Tranbsond® 1:8 1:8 
 Particle size <38µm <38µm 
Four months Release 65.29 55.52 
 Solubility 16   50 
 Ratio powder: Tranbsond® 1:6 1:10 
 Particle size <38µm <38µm 
Two weeks Release 220.07 141.87 
 Solubility 16   3 
 Ratio powder: Tranbsond® 1:6 1:10 
 Particle size >38µm >38µm 
 
 
8.1.7 SEM images of Transbond® mixed with powder from SRFGDs. 
The powder with the highest F release and the lower PO4 released was 
mixed with Transbond®. The test material seen in Figure 8-15 and Figure 
8-16 and control material seen in Figure 8-14 were screened with SEM to 
assess their morphology.  
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Figure 8-14 SEM images of Transbond® bonding material. 
   
Transbond® Magnification 20.30 Transbond® Magnification 50.69 
 
Figure 8-15 SEM images of powder (relative solubility 50, particle size 
<38µm, ratio of bead to Transbond® 1:10) mixed with Transbond®. 
 
   
Magnification 20.20   Magnification 50.43 
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Figure 8-16 SEM images of powder (relative solubility 1, particle size 
>38µm, ratio of bead to Transbond® 1:6) mixed with Transbond®. 
 
  
Magnification 20.30    Magnification 50.69 
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8.1.8 Profilometry scan of Transbond® mixed with powder from 
SRFGDs. 
The test and control materials were screened with profilometry to assess 
their morphology as seen in,  
The powder with highest solubility, a particle size of less than 38µm and the 
lowest ratio of 1:10 gave a different image following profilometry scan to the 
control material. Compared to Transbond® seen in Figure 8-17, all the test 
samples containing 1:10 ratio of SRFGDs to Transbond® appeared similarly 
flat seen in Figure 8-18, Figure 8-19, Figure 8-20, Figure 8-21 and Figure 
8-22. The particle size of powder from SRFGDs of either less or more than 
38 microns didn’t alter much the profilometry scan. The powder of SRFGDs 
with relative solubility of 1 or 50 appeared to produce profilometry scans the 
closest to the one produced by Transbond® as seen in Figure 8-18 and 
Figure 8-22.   
 
 
Figure 8-17 Profilometry scan of Transbond® bonding material. 
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Figure 8-18 Profilometry scan of powder with relative solubility 1 and 
particle size >38µm, mixed with Transbond®. 
 
Relative solubility 1, particle size 
>38µm, ratio of powder to 
Transbond® 1:6  
Relative solubility 1, particle size 
>38µm, ratio of powder to 
Transbond® 1:10 
               
 
Figure 8-19 Profilometry scan of powder with relative solubility 1 and 
particle size <38µm, mixed with Transbond®. 
Relative solubility 1, particle size 
<38µm, ratio of powder to 
Transbond® 1:6  
Relative solubility 1, particle size 
<38µm, ratio of powder to 
Transbond® 1:10 
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Figure 8-20 Profilometry scan of powder with relative solubility 16 and 
particle size >38µm, mixed with Transbond®. 
Relative solubility 16, particle size 
>38µm, ratio of powder to 
Transbond ®1:6  
Relative solubility 16, particle size 
>38µm, ratio of powder to 
Transbond ®1:10 
                        
 
Figure 8-21 Profilometry scan of powder with relative solubility 16 and 
particle size <38µm, mixed with Transbond®. 
Relative solubility 16, particle size 
<38µm, ratio of powder to 
Transbond ®1:6  
Relative solubility 16, particle size 
<38µm, ratio of powder to 
Transbond ®1:10 
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Figure 8-22 Profilometry scan of powder with relative solubility 50 and 
particle size <38µm, mixed with Transbond®. 
Relative solubility 50, particle size 
<38µm, ratio of powder to 
Transbond®1:6  
Relative solubility 50, particle size 
<38µm, ratio of powder to 
Transbond®1:10 
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8.1.9 Bond strength of test and control (Transbond®) materials 
In order to assess whether the bond strength of test and control material 
would be clinically acceptable I investigated whether storage temperature 
would produce a difference. Results in Figure 8-23 show no statistical 
significant  difference for flexural modulus of elasticity and flexular stress in 
samples stored in controlled room temperature or 37°C to mimic oral 
conditions. 
 
Figure 8-23 Flexular modulus of elasticity and stress mean±SD in n=10 
samples of Transbond® bonding material. 
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8.2 Questionnaire to orthodontist-members of the British Orthodontic 
Society 
The response rate was 7.85% (115/1,464) and the fully completed 
questionnaires were 105/115 (91.30%). Majority of responders were females 
(55.2%) and the mean age for all responders was 48 years old and the 
median 47. The median year for obtaining orthodontic qualification was 
1997. Based on the responses the median risk for developing WSLs during 
FAOT was estimated to be 20% and the mean 42.86%. Majority of 
responders (81.3%) would consider using the SRFGDs if proven effective 
clinically. Results on the multiple responses questions are shown in Figure 
8-24, Figure 8-25, Figure 8-26, Figure 8-27, Figure 8-28, Figure 8-29, Figure 
8-30, Figure 8-31 and Figure 8-32.  
 
Figure 8-24 Problems for patients with WSLs identified by dentists 
during FAOT. 
 
 
Count=number of dentists who have WSL problem(s) with patients 
$Problems=problems for patients with WSLs  
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Figure 8-25 Protocol followed to prevent WSLs during FAOT. 
 
Count=number of dentists who follow each protocol to prevent WSLs 
Figure 8-26 The most important risk factor for developing WSLs 
identified by responders. 
 
Count=number of dentists who report the most important risk factor for 
developing WSLs 
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Figure 8-27 Second most important factors for developing WSLs 
identified by responders. 
 
Count=number of dentists who report the second most important risk factor 
for developing WSLs 
Figure 8-28 Third most important factor for developing WSLs identified 
by responders. 
 
Count=number of dentists who report the third most important risk factor for 
developing WSLs 
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Figure 8-29 Agreement with risk factors for developing WSLs identified 
in the literature. 
 
Count=number of dentists who agree with risk factor for developing WSLs 
 
Figure 8-30 Methods of diagnosis of WSLs as identified by responders. 
 
Count=number of dentists using different methods to detect presence of 
WSLs, $Presence= methods of diagnosis of presence of WSLs 
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Figure 8-31 Methods of assessment of severity of WSLs as identified 
by responders. 
 
Count=number of dentists using different methods to assess severity of 
WSLs, $Severity=methods of assessment of severity of WSLs. 
Figure 8-32 Methods to arrest/treat WSLs during and/or after 
completion of FAOT as identified by responders. 
 
Count=number of dentists using different methods to arrest/treat WSLs 
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8.3 Socio-economic status (SES) of eligible participants in clinical study 
After 10 months of recruitment, an interim report was produced and 
presented in an international conference for a total of 91 eligible participants 
who had been informed about the study. Amongst them 63/91 volunteered to 
participate in the clinical trial whereas 28/91 declined. For those who refused 
to participate, the majority (12/28 or 43%) were living in least deprived areas 
and the minority (4/28 or 14%) in most deprived areas. For those who 
agreed to participate, the results were almost the opposite. The majority 
(20/63 or 32%) belonged to the third quartile across the spectrum of the MDI 
(MDI 17.37-31.26) whereas the minority (10/63 or 16%) belonged to the 
least deprived group.    
After two years of recruitment, a total of 175 eligible participants had been 
informed about the study; 112 refused to participate. Similar to findings from 
the interim report, majority of volunteers and the smallest number of refusals 
to participate were coming from people living in the most deprived areas. For 
those who agreed to participate the smallest number came from the least 
deprived areas. Seen in Figure 8-33, majority of refusals were coming from 
the second and third quartile across the spectrum of the MDI (MDI 6.03-
13.92 & 13.92-31.42).   
 
Figure 8-33 MDI of eligible participants after two years of recruitment. 
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8.4 Clinical study 
8.4.1 F release from test and placebo bead  
To confirm release of F, the test beads (one containing F and one placebo 
bead) together with their plastic holders were left in 5ml of de-ionised water 
for a period of one month. Every week for one month, .5ml of de-ionised 
water was measured for its F content using IC. The results are seen in 
Figure 8-34, confirming F release from the F devices and no F release from 
the placebo ones. F standard solutions containing 10, 1, .1 and .01 ppm F 
were used to test reproducibility of measurements.  
 
Figure 8-34 Mean weekly F release from placebo and SRFGDs in de-
ionised water for a month. 
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8.4.2 Recruitment of volunteers for clinical trial 
Based on the sample size calculation recruitment of n = 60 volunteers for the 
clinical study began in November 2008 following favourable opinion of the 
Leeds Central Research Ethics Committee and it continued for two years.  
In the flowchart of the study seen in Figure 8-35, a total 325 envelopes were 
posted to potential participants as identified through the booking system of 
the department; 150 were found not to fulfil inclusion criteria looking through 
their dental notes; the remaining 175 were eligible participants. From eligible 
participants n=63 agreed to participate in the study thus the participation 
refusal rate was 64% (112/175). The study was completed by 40 participants 
thus the failure to complete rate was 23.8% (15/63). The CONSORT flow 
diagram is seen in Figure 8-36.  
 
 
Figure 8-35 Flow-chart of participants in clinical study. 
 
 
 
 
 
 
 
 
 
 
 
• Not fulfilling inclusion criteria (n=150) 
Potential participants (n=325) 
• Declined participation (n=112) 
Eligible participants (n=175) 
• Failed to complete study (n=23) 
Study volunteers (n=63) 
Study completed  (n=40) 
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Figure 8-36 CONSORT clinical study flow diagram 
 
 
8.4.3 Randomisation 
The randomisation list was provided by a statistician and was produced by a 
computerised random number generator. The codes were broken by the 
supervisors at the end of the study and the list is found in the Appendix 
(Appendix No 13). 
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8.4.4 Demographics of volunteers 
The demographic characteristics of potential participants and volunteers are 
shown in Table 8-6, Table 8-7, Table 8-8 and Table 8-9. 
 
Table 8-6 Demographic characteristics of eligible participants who 
declined participation n=112. 
 Age (years) MDI Gender 
Range 8-17 3.14-59.05 54 Males 
Mean 13.57 19.17 58 Females 
Median 13 13.2  
 
Table 8-7 Demographic characteristics of study volunteers n=63. 
 Age (years) MDI Gender 
Range 9 - 17 3.46 – 55.53 30 Males 
Mean 12.93 22.65 33 Females 
Median 13 20.00  
 
Table 8-8 Demographic characteristics of volunteers who failed to 
complete study n=23. 
 Age (years) MDI Gender 
Range 10 - 17 3.46 – 52.52 11 Males 
Mean 12.95 24.94 12 Females 
Median 13 29.11  
 
Table 8-9 Demographic characteristics of volunteers who completed 
study n=40. 
 Age (years) MDI Gender 
Range 9 – 17 4.12 – 55.53 19 Males 
Mean 12.9 20.94 21 Females 
Median 13 19.73  
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8.4.5 Participants screening failures 
Eight potential participants were screening failures as they did not fulfil 
inclusion criteria e.g. they had missing upper lateral incisors.  
8.4.6 Adverse events 
No adverse events were reported during the study. 
 
8.4.7 Volunteers lost to follow-up 
Eight volunteers were lost to follow up. 
 
8.4.8 Protocol deviation 
In two cases there was a protocol deviation with the SRFGDs placed 
unilaterally due to space shortage to fit the SRGFD onto the orthodontic 
wire. 
 
8.4.9 Volunteer withdrawals 
Sixteen participants withdraw from the study. 
 
8.4.10 Duration of treatment for volunteers who completed the study 
The duration of FAOT for volunteers who completed the study was from 5 
to 39 months with a mean of 16.60±1.18 months and a median time of  17 
months. 
 
8.4.11 DMFT(S)/dmft(s) 
At the start of the study the mean DMFT was 0.79±1.6 with a maximum 
value of 8.00. In the primary dentition the corresponding mean dmft was 
0.03±0.25 with a maximum value of 2.00. The mean DMFS was 2.46±5.73 
and a maximum value of 20.00. In the primary dentition the corresponding 
mean dmfs was 0.03±0.25 with a maximum value of 2.00.    
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8.4.12 Plaque Index 
The Löe Plaque Index has a range from 0-3 and it was used on teeth 16, 
12, 24, 36, 32, 44 (FDI notation) at the start of the study. The mean index 
was 0.62±0.35.  
 
8.4.13 Gingival Index 
The Löe Gingival Index has a range from 0-3 and it was used on teeth 16, 
12, 24, 36, 32, 44 (FDI notation) at the start of the study. The mean index 
was 0.46 ± 0.33. 
 
8.4.14 Satisfaction questionnaire to orthodontists 
The return of the satisfaction questionnaire given to orthodontists at the 
end of the study was 79.3% (n=50/63) and the replies can be seen in the 
following table (Table 8-10).  
 
Table 8-10 Replies from orthodontists to satisfaction questionnaire 
post FAOT with SRFGDs. 
 Having the 
SRFGDs 
was easy 
Having the 
SRFGDs 
was difficult 
Placement of 
SRFGDs was 
easy 
Placement of 
SRFGDs was 
time consuming 
SRFGDs 
interfered 
with braces 
Agree  34.92% 
(22/63) 
63.49% 
(40/63) 
44.44% 
(28/63) 
17.46%  
(11/63) 
60.31% 
(38/63) 
Disagree  44.44% 
(28/63) 
15.87 % 
(10/63) 
44.44% 
(28/63) 
66.66%  
(42/63) 
39.68% 
(25/63) 
Strongly 
disagree 
20.63% 
(13/63) 
20.63% 
(13/63) 
11.11% 
(7/63) 
15.87%  
(10/63) 
n/a 
 
8.4.15 Satisfaction questionnaire to volunteers 
The return of the satisfaction questionnaire given to volunteers at the end 
of the study was 57.81% (n=37/64). The replies can be seen in the 
following table (Table 8-11). 
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Table 8-11 Replies from volunteers to satisfaction questionnaire post 
FAOT with SRFGDs. 
 Having the 
SRFGDs was 
easy 
Having the 
SRFGDs was 
difficult 
SRFGDs was 
uncomfortable 
Different without 
SRFGDs 
Yes  32.43% (12/37) 54.05% (20/37) 75.67% (28/37) 32.43% (12/37) 
No  67.56% (25/37) 45.94 % (17/37) 24.32% (9/37) 40.5% (15/37) 
 
8.4.16 Breakage/loss of SRFGDs 
On two occasions there was loss of the SRFGDs whilst the orthodontic wire 
was changed. 
 
8.4.17 Incidence of WSLs 
Presence/absence of WSLs on the buccal surfaces of the maxillary anterior 
permanent teeth was assessed at the start of the study using hand-held 
QLF™ and digital photographs and at the end of the study using digital 
photographs only. 
 
On a subject level amongst those who completed the study (n=40/63 or 
63.49%) the number of subjects who had WSLs (prevalence) at the start 
was  n=2/63 or 3.17% and at the end was n=15/40 or 37.5%. The number of 
subjects who developed WSLs during FAOT (incidence) was n=13/40 or 
32.5%. 
 
On a tooth level from 6x63=378 teeth examined at the start of the study 
6x40=240 teeth were available for examination at the end. The six teeth 
examined were the maxillary permanent central, lateral incisors and canines. 
The number of teeth with WSLs at the start of the study (prevalence) was 
n=2/378 or 0.0053% and the number of teeth with WSLs at the end was 
n=28/240 or 11.67%. Teeth which developed WSLs during the course of the 
study (incidence) was 26/240 or 10.83%.  
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We used a Zero Inflated Poisson regression model to account for factors 
leading to appearance of WSL areas on individuals as well as factors that 
affect severity of the WSL presence. Measures of model fit are seen in Table 
8-12, showing good fit of the model with p value (prob> LR) 0.000. WSL 
teeth count was used as the dependent variable and Code 
(placebo/SRFGDs), GI at the start of the study, PI at the start of the study, 
MDI, DMFT, DMFS as the independent variables. Results were adjusted for 
the effect of age, gender, outcome and duration. 
 
Table 8-12 Measures of model fit for the count of teeth with WSLs after 
completion of the study 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
BIC used by Stata:             143.818   AIC used by Stata:             115.958
BIC:                          -117.199   BIC':                            6.592
AIC:                             1.841   AIC*n:                         115.958
ML (Cox-Snell) R2:               0.461   Cragg-Uhler(Nagelkerke) R2:      0.530
McFadden's R2:                   0.302   McFadden's Adj R2:               0.101
                                         Prob > LR:                       0.000
D(50):                          89.958   LR(11):                         38.982
Log-Lik Intercept Only:        -64.470   Log-Lik Full Model:            -44.979
Measures of Fit for zip of WSLCOUNTpost
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Table 8-13 Zero Inflated Poisson regression model on a subject level 
for the presence and severity of WSL. Coefficients and 95% C.I. 
transformed at the natural logarithm. 
 
 
 
The second part of the analysis seen in Table 8-13, showed that for each 
unit increase in the duration of the treatment the odds of a patient to have no 
WSL teeth decrease by exp (-0,3272842) = 0.72  (p=0.034). The 95% 
Confidence Interval for this estimate is (0.533, 0.975), seen Figure 8-37. The 
odds ratio is 0.72 with 95% Confidence Interval from 0.533 to 0.974. A closer 
inspection of the results leads to Figure 8-38, where it becomes quite clear 
that this inference is mostly due to the difference encountered within the 
withdrawn group of patients and not to the ones who completed the therapy. 
Unfortunately the sample size does not allow for the reliable estimation of a 
p-value for the described interaction and yields non statistically significant 
differences for the effect of duration on presence of WSL teeth within each 
group separately. 
Vuong test of zip vs. standard Poisson:            z =     3.36  Pr>z = 0.0004
                                                                              
       _cons    -8.755239   4.856172    -1.80   0.071    -18.27316    .7626827
       PIpre     4.915528   4.155787     1.18   0.237    -3.229665    13.06072
       GIpre     7.877972   3.552776     2.22   0.027     .9146601    14.84128
      Gender     4.054905   2.374391     1.71   0.088    -.5988154    8.708625
    Duration    -.3272842   .1540246    -2.12   0.034    -.6291668   -.0254016
inflate       
                                                                              
       _cons    -2.469436   2.530165    -0.98   0.329    -7.428468    2.489596
        DMFS    -.0823581   .0542822    -1.52   0.129    -.1887493    .0240331
       GIpre     1.978042   .7819115     2.53   0.011     .4455239    3.510561
     MDI2010      .059785   .0130157     4.59   0.000     .0342746    .0852953
        DMFT     .3305468   .2085294     1.59   0.113    -.0781634    .7392569
         Age    -.0632938   .1312121    -0.48   0.630    -.3204648    .1938771
     Outcome     -.450532   .5590274    -0.81   0.420    -1.546206    .6451415
        Code     1.056139    .504896     2.09   0.036     .0665611    2.045717
WSLCOUNTpost  
                                                                              
WSLCOUNTpost        Coef.   Std. Err.      z    P>|z|     [95% Conf. Interval]
                                                                              
Log likelihood  = -44.97879                       Prob > chi2     =     0.0001
Inflation model = logit                           LR chi2(7)      =      30.65
                                                  Zero obs        =         44
                                                  Nonzero obs     =         19
Zero-inflated Poisson regression                  Number of obs   =         63
125 
 
 
Figure 8-37 Data distribution for presence of WSLs on a subject level 
according to duration of FAOT. 
 
 
 
No=subjects who did not develop WSLs during clinical study 
Yes=subject who developed WSLs during clinical study 
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Figure 8-38 Data distribution for presence of WSLs on a subject level 
according to duration of FAOT index by outcome of the study. 
 
 
Completed clinical study=40 subjects, withdrawn=23 subjects 
 
As seen in Table 8-13 and in Figure 8-39, for each 0,1 unit increase in the GI 
at the start of the study, the odds of a patient to have no WSLs on his/her 
teeth increase by exp(7,88) = 2450 times  (p=0.027). That is, for a 0,1 unit 
increase in the GI at the start of the study, the odds of a patient to have WSL 
teeth increase by 245 times. The C.I. for this estimate is (0.914 – 14.841) 
seen in Table 8-13. The odds ratio for GI at the start of the study is 2638.52 
with 95% C.I. from  2.49 to 2789240.79. The wide C.I. for this estimate is 
due to the small sample size so we cannot quantify the size of the effect.   
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Figure 8-39 Data distribution for presence of WSLs on a subject level 
according to gingival index at the start of the study. 
 
No=number of subjects who did not develop WSLs in the clinical study 
Yes=number of subjects who developed WSLs in the clinical study 
 
A closer inspection of the results leads to Figure 8-40, where it appears that 
this inference is mostly due to the difference encountered within the 
withdrawn group of patients and not to the ones who completed the study. 
Again, unfortunately the sample size does not allow for the reliable 
estimation of a p-value for the described difference and yields non-
statistically significant differences for the effect of GI at the start of the study 
on presence of WSL teeth within each group separately. Therefore the GI 
index at the start of the study is of importance only for those who do not 
complete the treatment.  
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Figure 8-40 Data distribution for presence of WSLs on a subject level 
according to gingival index by outcome of the study. 
 
 
Completed clinical study=40 subjects, withdrawn=23 subjects 
 
8.4.18 Kappa coefficient estimation for incidence of WSLs 
The intra-examiner reliability expressed as kappa score for 
presence/absence of WSLs assessed on digital photographs is estimated 
0.82 showing good agreement (Randolph, 2008). 
 
8.4.19 Severity of WSLs 
Although severity of WSLs was assessed using the surface area of the WSL 
in relation to the whole buccal surface area of the tooth and it was expressed 
as a percentage of the whole buccal area at the start and at the end of the 
study data distribution led to an analysis of the obtained sample of patients 
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with no statistical significant results in any case. Instead the number of teeth 
with WSL on each participant was used as a measure of the severity met. 
 
According to the first part of the Zero Inflated Poisson regression seen in 
Table 8-13, MDI, GI at the start of the study and use of placebo/SRFGDs 
(Variable named Code) are variables statistically significant for the count of 
teeth with WSL in individuals. 
 
If the MDI index of a patient was to increase by one the expected number of 
teeth with WSL would increase by a factor of exp (0.059785) = 1.06 (6%) 
while holding all other variables in the model constant (That is a 60% OR 
increase for a 10 unit MDI difference). Thus, the higher the MDI index, the 
more WSL teeth predicted (p<0.001), seen in the following figure (Figure 
8-41). The odds ratio for this variable is 1.06 with 95% Confidence Interval 
from 1.035 to 1.089.  
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Figure 8-41 Number of teeth with WSLs predicted as per Multiple 
Deprivation Index. 
 
#=number of teeth 
 
If the GI at the start of the study of a patient was to increase by one the 
expected number of teeth with WSL would increase by a factor of exp 
(1.978042) = 7.23 times, while holding all other variables in the model 
constant. Thus, the lower the GI at the start of the study, the more WSL 
teeth predicted (p=0.011) as seen in the following figure (Figure 8-42). 
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Figure 8-42 Number of teeth with WSLs predicted according to GI at the 
start of the study. 
 
#=number of teeth 
 
A closer inspection of the results leads to Figure 8-43, where it appears that 
this inference is mostly due to the difference encountered within the 
withdrawn group of patients and not to the ones who completed the therapy 
where differences seem to be non-significant. Again, unfortunately the 
sample size does not allow for the reliable estimation of a p-value for the 
interaction between outcome and GI at the start and yields non-statistically 
significant differences on the count of teeth with WSL presence. Therefore 
the GI index at the start of the study is of importance only for those who do 
not complete the treatment. 
  
132 
 
Figure 8-43 Data distribution for presence of WSLs on a subject level 
according to gingival index by outcome of the study. 
 
Completed clinical study=40 subjects, withdrawn=23 subjects 
 
The expected number of WSL teeth for a placebo patient is exp (1.05639) = 
2.88 higher than the expected number of a SRFGDs patient while holding all 
other variables in the model constant (p=0.036). The odds ratio for use of a 
placebo is 2.87 with 95% C.I. from 1.069 to 7.734. Thus more WSLs are 
expected for the placebo patients than for the patients receiving the 
treatment seen in the following figure (Figure 8-44). 
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Figure 8-44 Difference in presence of WSLs on a subject level between 
those who received treatment and those who received the 
placebo. 
. 
 
Count=number of subjects, #=number 
 
As shown in Figure 8-45, the result again seems to be deriving by the group 
of therapy completion and not by the withdrawn one. 
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Figure 8-45 Difference in presence of WSLs on a subject level between 
those who received treatment and those who received the 
placebo. 
 
Completed=40 subjects, withdrawn=23 subjects, Count=number of subjects, 
#=number
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9 Discussion 
 
9.1 In-vitro exploratory study 
The aim of the exploratory study was to assess primarily F and PO4 release 
with IC but also bond strength of a bonding material produced by mixing a 
composite resin (Transbond®) with SRFGDs in powder form.  
 
The first step was to check the materials for any background F and PO4 
release that could mask the results. It was confirmed that Transbond® had 
minimal F release (1.27ppm was the maximum F release) and PO4 
(51.62ppm was the maximum PO4 release) over 28 days as seen in Figure 
8-3 and Figure 8-4. The storage medium chosen was de-ionised water in 
order to enhance ion release from the material over time. The samples were 
prepared using a PTFE mould seen in Figure 7-1 to ensure similar surface 
area.  
 
The storage medium for the study had to be clearly defined, not 
compromising ion release from test and control materials and if possible to 
mimic intra-oral conditions or at least not to create an environment where 
materials would behave completely differently than in the mouth. For these 
reasons AS and different types of water namely de-ionised, distilled, tap and 
sterile waters were assessed for their F and PO4 release. Samples were 
prepared in an identical way and after 14 days the results showed that AS 
were more stable for PO4 release compared to tap and distilled water as 
seen in Figure 8-2. Also PO4 release from distilled and de-ionised water was 
closer to zero as expected. In terms of F release as seen in Figure 8-1, the 
AS was again stable and showed the highest F release with a range of 0.52-
0.65 ppmF with all other storage mediums showing F release of closer or 
less than 0.1 ppmF. Choosing storage mediums with minimal ion release 
(either F and/or PO4) would enhance ion release since the material would 
appear to be supersaturated in an “empty” liquid storage medium. On the 
other hand release levels were low compared to SRFGD either in a bead or 
powder forms therefore would provide a minimal background level that 
would not overlap with F and PO4 from test materials.  
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9.1.1 F and PO4 release from powder from SRFGDs in AS 
All different types of powder were assessed for their F and PO4 release prior 
to mixing with Transbond®. The ideal was to combine the highest F release 
with the lowest PO4 release in order to meet both objectives. The primary 
objective was to enhance F presence and prevent demineralisation but also 
minimise PO4 release which shows degradation of the test material as it is a 
PO4 based glass. Cumulative release after two months showed that powder 
with solubility 16 and a particle size of more than 38µm had the highest F 
release (365.28 ppmF) and also the highest PO4 release (192.64 ppmPO4). 
This powder would have an enhanced F presence but at the expense of 
material loss. The powder with the lowest PO4 release had solubility of 1 and 
a particle size of less than 38µm (149.90 ppmPO4) whereas its F release 
was 297.27 ppmF i.e. 18.6% less than the highest. The powder with 
solubility of 1 and a particle size of more than 38µm would better meet both 
objectives as it had the second highest F release, with a difference of 
12.30% (320.64 ppmF) and PO4 release (180.48 ppmPO4) increased by 
16.94% more compared to the lowest as seen in Figure 8-6 and Figure 8-7.  
 
9.1.2 Bond strength of test and control materials 
A study investigated differences for flexural modulus of elasticity and flexular 
stress in samples stored at a controlled room temperature or 37°C. Results 
showed higher flexural stress at 37°C by 9.1% and lower flexular modulus of 
elasticity by 12.38% as seen in Figure 8-23. Both differences were 
considered not clinically significant therefore storage of samples in AS in 
controlled room temperature was acceptable. 
 
9.1.3 Summary of in-vitro exploratory study 
With all the limitations of an exploratory study in order to develop a 
methodology to test a new material for its bond strength, F and PO4 release, 
a number of parameters were investigated. Storage medium and room 
temperature for storage of material samples need to be controlled so as not 
to alter the performance of the material. This way the methodology is 
reproducible and it enhances the strength of the in-vitro environment 
compared to clinical studies which are to test the outcome in question 
without any confounding variable. 
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The PFTE mould was chosen to produce samples with identical shape and 
size whether tested for F, PO4 release, flexular modulus of elasticity or 
flexural stress. The concern was again reproducibility and well defined and 
controlled settings. 
Samples were scanned with profilometry and SEM in order to obtain a close 
up “image” of their surface morphology to assess for “breaks” as they had 
been reported in cases on enamel sealants (Frazier et al., 1996). 
IC has a detection limit of 0.001ppm (or 1ppb) in liquids free of organic 
material. It is possibly the method of choice to assess both F and PO4 
release as it can detect all ions. There was a marked decrease in F and PO4 
release from SRFGDs in the form of powder left in AS or “blocked” in 
composite resin of the control material.  
Investigation of all 40 different types of powder solubility, ratio of powder to 
control material and particle size over six months gave an insight as to how 
the test material would perform. One sample for each of the 40 different 
types was investigated therefore no conclusions could be made. The next 
step would be to increase the sample size for all 40 different combinations to 
at least n=5 giving a total of n=200 samples to investigate. The alternate 
would be to increase the sample size only for the combinations showing 
promising results from the exploratory study. The most promising findings 
came from the powder with solubility of 1 and a particle size of more than 
38µm. It showed the second highest F release, with a difference of 12.30% 
(320.64 ppmF) and PO4 release (180.48 ppmPO4) increased by 16.94% 
more compared to the lowest. When powder was mixed with Transbond® 
the most promising results after six months were obtained when powder with 
particle size of less than 38µm was mixed at a ratio of 1:8 with Transbond® 
with solubility of either 1 or 16. These three different types of powder would 
need to be tested on a larger scale to detect F and PO4 release after mixing 
with composite resin and also bond strength of the test material bonded onto 
human premolar teeth.        
 
9.2 Questionnaire to orthodontist-members of the British Orthodontic 
Society 
The response rate to the questionnaire was very low (7.85%) even though it 
was an electronic questionnaire emailed twice via the British Orthodontic 
Society and it concerned a clinical risk during every day practice of FAOT. 
The median year for obtaining orthodontic qualification for responders were 
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1997, that is 5 years after the last review on prevalence/incidence of WSLs 
(Mitchell, 1992b). Early termination and need for restorative care were the 
most common problems reported which indicated either early diagnosis of 
WSLs and early action or late diagnosis of WSLs with all the consequences 
thereof. F was at the centre of prevention of WSLs either as daily mouth 
rinse or tooth paste, alongside professional plaque removal. Oral hygiene, 
diet and duration of FAOT were believed to be important factors for 
developing WSLs. The orthodontist may not have direct control though as 
use of F, oral hygiene and diet depends on compliance and the behaviour of 
the individual whereas professional plaque removal may be performed by 
other members of the dental team, leaving the duration of FAOT to be under 
the direct supervision of the orthodontist. For majority of risk factors as 
identified in the literature responders agreed that they contribute to 
development of WSLs. Few responders though agreed that the age and 
gender of the patient played a significant role. Clinical examination with or 
without photographs were the main tools for presence and severity of WSLs 
without a specific methodology employed. In the unfortunate situation where 
WSLs did develop the majority of responders would discuss the problem 
with the patient/parent(s) offering diet and oral hygiene advice. Their next 
step though would be to end FAOT and allow self-healing rather than 
employ microabrasion or F application, either at home or in surgery.     
 
9.3 Socio-economic status of eligible participants in clinical study 
The MDI is part of the English Indices of Deprivation 2010 available from the 
Department for Communities and Local Government, Indices of Deprivation 
2010 and it is used to assess the socio-economic-status of eligible 
participants. The 2010 Index has a range of 1.86-76.76 at Lower Layer 
Super Output Area and it was constructed by combining the seven 
transformed domain scores, using the following weights: 
 Income (22.5%) 
 Employment (22.5%) 
 Health and Disability (13.5%) 
 Education, Skills and Training (13.5%) 
 Barriers to Housing and Services (9.3%) 
 Crime (9.3%) 
 Living Environment (9.3%) 
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Majority of eligible participants who volunteered to participate in the study 
and the smallest number of refusals lived in the most deprived areas 
according to the MDI. Eligible participants living in the least deprived areas 
formed the smallest proportion of volunteers to the study. Majority of refusals 
came from eligible participants living in areas with a MDI from the second 
and third quartile across the range. Participation in a research study is 
voluntary and this fact by nature can bring imbalance to the study sample 
which could introduce bias. In this study this imbalance was investigated 
because socio-economic-status has a strong relationship with provision of 
FAOT (Germa et al., 2010) and because of the number of eligible 
participants refusing participation was high (64% or 112/175). For future 
studies it is probably unethical to include socio-economic status amongst the 
inclusion criteria but a statistical sampling technique may need to be 
employed rather than having a convenience sample.  
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9.4  Clinical study 
9.4.1 Recruitment of volunteers for clinical study 
Recruitment of volunteers lasted for almost two years with a total of 325 
envelopes posted to potential participants. Almost half of them (n=150/325 
or 46.1%) did not fulfil inclusion criteria and this high percentage highlights 
the need for development of protocols for effective identification via hospital 
electronic records or for less strict inclusion criteria. Better electronic record 
keeping or logging patients diagnosis would help exclude or include groups 
of patients. In this study patients with missing maxillary lateral permanent 
incisors were excluded and since in a hospital many such hypodontia cases 
would have been referred it would have been useful to be able to identify 
such cases electronically and avoid inviting them to participate in a study 
where they cannot take part anyway.  
As discussed previously many declined participation (n=112/175 or 64%) 
which was of great concern and possibly a weakness of this study. However 
participation in a research study is voluntary, however it may be more 
difficult to recruit children for clinical research studies in another department. 
The voluntary nature of recruitment may produce an unbalanced sample 
which could introduce bias to the study. In this study participants and those 
who declined participation came from different socio-economic background. 
Majority of volunteers and the smallest number of refusals to participate 
were coming from people living in the most deprived areas. For those who 
agreed to participate the smallest number came from the least deprived 
areas. This finding may be of interest for recruitment in future studies but 
also to be quantified whether it could have a significant impact on the 
sample.   
   
 
9.4.2 Randomisation 
Patients were randomised based on their gender because it was believed 
that gender played a role in seeking FAOT, oral hygiene and there was no 
clear outcome as to whether it should be considered a risk factor for 
development of WSLs.    
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9.4.3 Demographics of eligible participants, volunteers and volunteers 
who failed to complete the study 
There was no great difference in mean and median value for age and MDI 
index with almost equal number of boys and girls who completed the study 
(n=40/60 or 66.67%). The final study group which was analysed appeared to 
be balanced for these three variables and the same applied for the group 
who failed to complete the study (n=23/60 or 38.33%). For those who 
declined participation majority were females (58 compared to 54 males) and 
they were slightly older by 0.64 months but still the median age was 13 
years old for all groups.     
 
9.4.4 Participants screening failures, adverse events and protocol 
deviation 
Inclusion criteria were not fulfilled in only eight cases from those who 
volunteered to participate. It is the norm to accept cases with high index of 
orthodontic treatment needs in a hospital setting as these would include 
hypodontia cases with maxillary lateral permanent incisors frequently 
missing. On the other hand these teeth seem to be frequently affected by 
WSLs and due to their location they are of aesthetic concern and value in 
terms of prevention of WSLs. In two cases there was a protocol deviation 
due to space shortage to fit bilaterally the glass bead in non-extraction 
cases. Still one bead was placed so the study was not suspended.  
 
9.4.5 Volunteers lost to follow-up and withdrawals 
Eight volunteers were lost to follow-up either because they stopped FAOT or 
moved out of the area. The remaining 16 volunteers who withdrew from the 
study felt that the SRFGDs were uncomfortable or they were “fed up” as it 
was frequently quoted. Volunteers mainly withdrew from the study either at 
the beginning or towards the end of the study; this could possibly indicate 
difficulties with FAOT itself as there is an adjustment period at the start of 
FAOT and patients may well have been overwhelmed or at the end of FAOT 
when patients were tired from a long course of treatment. 
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9.4.6 Duration of treatment for volunteers who completed the study 
The mean duration of FAOT was 16.60±1.18 months with a wide range of 
five to 39 months. The median time (17 months) was not different to the 
mean time so it is clear that the five months duration of FAOT was an outlier.   
 
9.4.7 DMFT(S)/dmf(s) 
In general these indices were low at the start of the study and few subjects 
had the highest values. During FAOT in some cases extractions are 
requested increasing the DMFT by the end of the study however these 
extractions are not a result of caries and should not be included in the post-
FAOT DMFT(S) measurement.   
 
9.4.8 Plaque and Gingival Index 
The mean plaque and gingival index had a range from 0-3 and at the start of 
the study it was low; 0.620.35 for the plaque and 0.460.33 for the gingival 
index. This is probably expected as the participants were about to start 
FAOT and control of oral hygiene is of paramount importance.   
 
9.4.9 Satisfaction questionnaire to orthodontists 
There was a quite good return rate from orthodontists of 79.3% (n=50/63) 
and even though there was a small number of orthodontists who replied 
(n=7) they treated 63 different cases therefore for each treated case the 
orthodontist was given a questionnaire. Results showed that orthodontists 
overall were not satisfied with the SRFGDs as they felt it interfered with the 
orthodontic wire and brackets by 60%. Time was not a problem as 80% 
either disagreed or strongly disagreed that they were time consuming. 
Placing SRFGDs seemed to be a difficult task for 55% of them. There were 
mixed results whether it was easy or difficult to have SRFGDs as part of 
their fixed appliance but that would probably depend on the case; for 
example a crowded dentition treated on a non-extraction basis would 
probably provide just sufficient space for the SRFGDs. Majority of 
orthodontists who treated volunteers in the study were under specialist 
clinical training thus lacking clinical experience, which may also contribute to 
the difficulties faced by them.    
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9.4.10 Satisfaction questionnaire to volunteers 
There was a good return rate from volunteers by 57.81% (n=37/64). Overall 
volunteers found it difficult (46%) to have the SRFGD in their mouth 
alongside their fixed appliance and it felt uncomfortable (76%). Interestingly 
though they felt that it would have been no different if the SRFGDs were not 
present (41%) therefore it may be that the fixed appliance could have been 
an equally contributing factor in their overall dissatisfaction.   
 
9.4.11 Breakage/loss of SRFGDs 
The limited number of losses and/or breakages of SRFGDs whilst the 
orthodontic wire was changed clearly indicate that the design of the 
appliance proved to be effective. 
 
9.4.12 Photographic technique for assessment of WSLs 
The photographic technique used followed the protocol of previous study 
(Kanthathas et al., 2005b). Staff members of the photography department 
were familiar with cross polarizing technique and used standard equipment 
in the photography laboratory like wall mount camera holders to take the 
photos. Photos were stored in JPEG format which allows lossy compression 
typically at a scale of 10:1 for digital images. This lossy compression means 
that some original image information is lost and cannot be restored, possibly 
affecting image quality.  
Assessment of presence and severity of WSLs was performed using digital 
32-bit coloured photographs and measuring the mean grey value on a pixel 
level using Adobe Photoshop® software as shown in Figure 7-8 to Figure 
7-16. Alternative methods to enhance data management based on their grey 
value would be to use black and white photos combined with a reference 
greyscale index. This approach would enhance standardisation and 
reproducibility of the technique for other researchers and/or examiners of the 
photos. Photos could also be stored and processed as 12-bit JPEG image 
provided it is a greyscale photo. Storage of photos in TIFF (Tagged Image 
File Format) format would use no compression and as a result files can be 
edited without losing image information and image quality.     
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9.4.13 Incidence of WSLs 
The six teeth examined for presence/absence of WSLs were the maxillary 
permanent central, lateral incisors and canines. The choice was based on 
the facts that these teeth are of most aesthetic concern due to their location 
and are frequently affected by WSLs as seen in Table 2-4.  
 
On a subject level amongst those who completed the study (n=40/63 or 
63.49%) the number of subjects who developed WSLs (incidence of WSLs) 
was 32.5% or n=13/40. The number of subjects with WSLs at the start of the 
study was n=2/63 or 3.17% and at the end was n= 15/40 or 37.5%. Previous 
review has reported a range for patients from 2-96% (Mitchell, 1992b) 
whereas material published from 1992 report a range from 10.7 - 73% as 
seen in Table 2-3.  
 
On a tooth level from 6x63=378 teeth examined at the start of the study 
6x40=240 teeth were available for examination at the end. The number of 
teeth with WSLs at the start of the study were n=2/378 or 0.0053% and at 
the end was n=28/240 or 11.67%. The number of teeth which developed 
WSLs (incidence of WSLs) during the course of the study was n=26/240 or 
10.83%. Previous review has reported a range from 0-24% (Mitchell, 1992b) 
and material published thereafter reported a range from 1.9-76.8% of teeth 
as seen in Table 2-3.  
 
Findings from this study appear to be low both on a subject level (32.5%) 
and 10.83% on a tooth level. Previous studies investigating WSLs on 
maxillary permanent teeth showed different results. In many studies (Banks 
and Richmond, 1994, Marcusson et al., 1997, Millett et al., 1999, Wenderoth 
et al., 1999, Banks et al., 2000, Ogaard et al., 2001) WSLs were scored 
using a variety of indices described in Table 2-1, for example index by 
Gorelick in 1982, Enamel Decalcification Index by Banks and Richmond 
1994, Geiger 1988. These indices have a range from 0-3 and WSLs are 
assessed as none, mild/moderate, severe leaving results open to discussion 
as to what is the difference between a mild, moderate and a severe WSL. 
Two studies (Trimpeneers and Dermaut, 1996, Tobin, 2001) categorised 
WSLs as being either present or absent. In a split mouth design study 12.7% 
of teeth in the control group developed WSLs (Trimpeneers and Dermaut, 
1996). In the other study with two parallel groups 19% of teeth in the control 
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group developed WSLs (Tobin, 2001). Findings from this study was 10.83% 
on a tooth level, much lower compared to aforementioned studies. 
 
Possible explanations for findings in this study are strict acceptance criteria 
for provision of FAOT in a hospital setting despite the increased orthodontic 
treatment needs however majority of previous studies though have been 
undertaken in a hospital setting. Another possible factor could be the 
methodology of diagnosis of WSLs using cross-polarised digital photographs 
which masks flash reflection (Robertson and Toumba, 1999) and improves 
visualisation of enamel defects (Willmot et al., 2000). The only other clinical 
study using cross-polarised digital photographs produced an interim report 
(Tobin, 2001). In-vitro investigation with brackets in place (Livas et al., 2008) 
reported that flash masking and 20ᵒ angle were suggested to reduce flash 
reflection (Benson et al., 2000). The need for equipment and possible 
training as it is difficult to focus as there is restricted flash output (Fleming et 
al., 1989) may be a prohibiting factor for such a method to be used in every 
day clinical practice.    
 
It was not the aim of this study to investigate all possible risk factors for 
development of WSLs nor to detect and quantify their relationship if there 
was any. Decision was made not to investigate them all as it would 
complicate the study protocol. Demographic data and data that was part of 
the patient standard clinical examination e.g. DMFT were collected. 
Statistical analysis showed that there was a statistically significant difference 
between the placebo and the test group in development of WSLs during 
FAOT (p=.036, with 95% C.I. .066 - 2.04).The expected number of WSL 
teeth for a patient having a placebo is exp (1.05639) = 2.88 higher than the 
expected number of a SRFGDs patient while holding all other variables in 
the model constant (p=.036). The odds ratio is 2.87 with 95% C.I. of 1.068 – 
7.734. That means that use of SRFGDs could reduce the risk for 
development of WSLs on a tooth level by an additional 2.88 times. That is on 
condition that standard protocol of brushing with 1,450 ppmF tooth-paste 
twice daily alongside daily use of 225 ppmF mouth-rinse is followed.   
 
A number of other variables appeared to be statistically important. For each 
unit increase in the duration of the treatment (range of 5-39 months) the 
odds of a patient not to have WSL teeth decrease by exp (-0,3272842) = 
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0,72 times (p=.034) with odds ratio of 0.72 and 95% C.I. of 0.533 to 0.974. 
Therefore the duration of FAOT increases the chances for a patient to 
develop WSLs. Duration of FAOT of more than 17 months (Marcusson et al., 
1997) or 24 months (Geiger et al., 1988) has also been identified as a risk 
factor in other studies. Duration of FAOT in this study had a range of 5-39 
months with a mean of 16.60 ± 1.18 months and a median time of 17 
months similar to the study by Marcusson et al. 1997. 
 
The MDI also appeared to increase the chances of developing WSLs during 
the course of FAOT with odds ratio of 1.06 and 95% C.I. of 1.034 – 1.089, 
thus an increase in the MDI score makes it more likely to develop WSLs. 
 
If the GI index (range 0-3) of a patient at the start of the study was to 
increase by one the expected number of teeth with WSL would increase by a 
factor of exp (1.978042) = 7.23 times, while holding all other variables in the 
model constant. Thus, the higher the GI index at the start of the study, the 
more WSL teeth predicted (p=0.011) with odds ratio of 2638.52 and 95% C.I. 
from 2.495 to 2789240.794. Increased GI index at the start of FAOT makes 
it more likely for WSLs to develop. The small sample size in this study did 
not allow reliable quantification of the effect of this variable hence the wide 
range for 95% C.I.. This index was also found to be a significant risk factor 
for development of WSLs in other studies (Zachrisson and Zachrisson, 
1971a, Ogaard et al., 2001). It is only logical that plaque induced gingival 
inflammation would be closely associated to development of WSLs the 
precursor state of dental decay. 
 
 
9.4.14 Kappa coefficient estimation for incidence of WSLs 
The primary outcome was presence of WSLs assessed by one examiner 
using cross-polarised digital photographs and the kappa score of 0.821 
showed very good intra-examiner reliability. There is no clear answer as to 
how many examiners should examine data and whether the same 
examiners should examine the data at the start and at the end of the study. 
The median duration of FAOT in this study was 17 months with n=63 
volunteers to be followed for the duration of the clinical study and that posed 
a risk of not having the same examiners. In case of a single examiner he/she 
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needs to be calibrated against a standard whereas in cases of multiple 
examiners they need to be calibrated against a standard and against each 
other. As a result the number of examiners multiplies the standard error 
produced by each examiner as well. For these reasons the decision was 
made to have one examiner to perform all assessments - the principal 
investigator - and since the study had a double-blind design there was no 
bias introduced.   
 
9.4.15 Severity of WSLs 
The data distribution from changes in area of WSLs would not allow 
statistical analysis therefore as a measure of severity the number of WSLs 
on each participant was used. A possible explanation might be the effect of 
polishing teeth after removal of bracket and bonding material. Use of 
polishing burs would not only remove bonding material but may also remove 
the outer surface of enamel hence altering WLSs if there are any. Based on 
that outcome the Zero Inflated Poisson regression model showed that MDI, 
GI at the start of the study and use of placebo/SRFGDs all predicted future 
development of WSLs. It is important to note that even though 40/63 
subjects completed the study the effect of those who failed to complete the 
study (n=23/63 or 36.5%) was also investigated in the statistical model. 
Sample size though was small for the two groups (those who completed and 
those who failed to complete the study) therefore reliable p-value estimation 
was not possible. Patient who had more WSLs at the end of the study would 
benefit more from a SRFGDs, in other words patients more prone to 
development of WSLs would benefit. The question remains how best to 
identify such patients.  
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9.5 Conclusions 
9.5.1 Conclusions from clinical study: 
 Incidence of WSLs on a subject level was 32.5% (n=13/40).The 
number of subjects with WSLs at the start of the study was n=2/63 or 
3.17% and at the end was n=15/40 or 37.5%. 
 Incidence of WSLs on a tooth level was n=26/240 or 10.83%. The 
number of teeth with WSLs at the start of the study were n=2/378 or 
0.0053% and at the end was n=28/240 or 11.67%.  
 There was a statistically significant difference between the placebo 
and the SRFGDs group in development of WSLs during FAOT. The 
expected number of WSL teeth for a patient having a placebo is exp 
(1.05639) = 2.88 higher than the expected number of a SRFGDs 
patient while holding all other variables in the model constant (p=.036, 
with 95% C.I. of 0.06 - 2.04 and odds ratio 2.88 with 95% C.I. of 1.06 
– 7.73). 
 The higher the MDI index, the more WSL teeth predicted (p<.001, 
with 95% C.I. of .03 - .08) with odds ratio 1.06 and 95% C.I. of 1.034 
– 1.089. If the MDI index (range 1.86 – 76.76) was to increase by one 
the expected number of teeth with WSL would increase by a factor of 
exp (0.059785) = 1.06 (6%) while holding all other variables in the 
model constant.  
 The higher the GI index at the start of the study, the more WSL teeth 
predicted (p=0.027, with 95% C.I. of .91- 14.84) and odds ratio of 7.87 
with 95% C.I. of 2.496 – 2789240.794. The wide C.I. results from the 
small sample size so even though an effect was detected it was not 
possible to quantify this effect. If the GI index (range 0-3) of a patient 
at the start of the study was to increase by 0.1, the expected number 
of teeth with WSL would increase by a factor of exp (7.88) = 245 
times, while holding all other variables in the model constant.  
 For each unit increase in the duration of the treatment (range of 5-39 
months) the odds of a patient not to have teeth with WSLs decrease 
by exp (-0,3272842) = 0.72 times (p=.034, with 95% C.I. of -.62 to -
0.2) and odds ratio of 0.72 with 95% C.I. of 0.533 – 0.974. 
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 There was a high percentage of eligible participants who did not 
volunteer to participate in the study (n=112/175 or 64%).  
 From those who volunteered to participate in the study n=40/63 
(63.49%) managed to complete it. From those who failed to complete 
the study (n=23 or 36.5%), eight were lost to follow-up and 16 
withdrew from the study. 
 Majority of volunteers and the smallest number of refusals were from 
people living in the most deprived areas around the hospital setting in 
Leeds, West Yorkshire, U.K. This may well have introduced bias to 
the study as it has produced an unbalanced sample in terms of their 
socio-economic background.   
 
9.5.2 Conclusions from electronic questionnaire emailed to members of 
the British Orthodontic Society: 
 The response rate was 7.85% (115/1,464) and the fully completed 
questionnaires were 105/115 (91.30%).  
 The median risk for development of WSLs was estimated by 
responders to be 20% and the mean risk 42.86%. 
 Early termination and need for restorative care were the main 
problems associated with WSLs.  
 Responders would primarily use clinical examination and secondly 
photographs to diagnose and quantify severity of WSLs.  
 F was at the core of the prevention protocol adopted by responders. 
 Poor oral hygiene, diet and duration of FAOT were believed to be the 
main three risk factors for development of WSLs. 
 Responders agreed with many risk factors identified in the literature 
(pre-existing WSLs, socio-economic status, duration of FAOT, DMFT 
and oral hygiene). 
 Responders did not agree that age and/or gender of the patient are 
risk factors for development of WSLs.   
 A variety of methods would be considered by responders to 
treat/arrest WSLs with the most popular ones being discussion with 
patient/parent, oral hygiene instructions and diet advice.  
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9.5.3 Conclusions from in-vitro study: 
 AS was the most appropriate storage medium compared to different 
types of waters to assess F and PO4 release from bonding materials.  
 AS had a background F release of 0.61±0.08 ppm F (mean±SD) and 
PO4 release of 70.25±4.84 ppm PO4 (mean±SD) over two weeks.  
 F and PO4 release from powder from SRFGDs mixed with a CR 
control bonding material (Transbond®) after six months showed that 
some types of powder showed higher F release and similar PO4 
release compared to artificial saliva. 
 Compared to artificial saliva, three types of powder from SRFGDs 
showed promising results in terms of high F release and low PO4 
release.  
a. Powder with particle size of less than 38µm, mixed at a ratio of 
1:8 with Transbond® and relative solubility of 1. After six 
months showed mean F release of 36.21 ppm F and mean 
PO4 release of 75.51 ppm PO4. 
b. Powder with particle size of less than 38µm, mixed at a ratio of 
1:8 with Transbond® and relative solubility of 16.After six 
months showed mean F release of 101.45 ppm F and mean 
PO4 release of 431.62 ppm PO4. 
c. Powder with relative solubility of 1 and particle size of more 
than 38µm, showed high F (320.64 ppm F) and low PO4 
release (180.48 ppm PO4) after two months. 
 Room temperature showed no difference for storage of materials 
tested for flexural modulus of elasticity and flexural stress in order to 
assess their bond strength in-vitro.  
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9.6 Rejection of null hypotheses 
From the aforementioned we failed to reject the first null hypotheses 
whereas there was a difference in the severity of WSLs assessed by the 
number of teeth with WSL(s) on each participant having SRFGDs compared 
to a placebo device. 
 
9.7 Future studies 
 Based on the inclusion criteria for the clinical study eligible 
participants should be identified in a more effective manner in an 
appropriate setting to maximise participation in the clinical study. 
 Specialists in orthodontics should test the SRFGDs rather than 
clinicians in training. 
 The duration of FAOT and the MDI of volunteers should be 
documented as it appears to increase the risk of developing WSLs. 
 GI at the start of the clinical study could be part of the 
inclusion/exclusion criteria as it appears to increase the risk of 
developing WSLs. However low GI may not be a requirement to 
provide FAOT and this may complicate recruitment.   
 MDI cannot be part of the inclusion/exclusion criteria as it would be 
unethical to exclude potential participants due to their socio-economic 
status as dictated by their MDI.  
 MDI needs to be documented in order to assess whether an 
unbalanced study sample has been obtained and if possible to assess 
and quantify risk of bias, if any. 
 Other risk factors for development of WSLs which have not been 
investigated in this study may need to be documented. These factors 
were frequency of tooth-brushing and use of F, mutans streptococci 
counts in plaque, lactobacilli counts in saliva, diet, gingivae clinical 
attachment and compliance with use of F mouth-rinse. This way they 
can be incorporated into a model for statistical analysis that can 
provide more clinically meaningful results since these confounding 
variables will be kept constant in the statistical model. 
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 Another method needs to be employed to increase number of 
responders to electronic questionnaires. A postal questionnaire may 
be more expensive but it may increase response rate. 
 Future studies should investigate a larger number of samples based 
on a sample size calculation to assess F, PO4 release and bond 
strength of orthodontic brackets bonded onto human teeth in-vitro. 
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11 Glossary of acronyms 
APF acidulated phosphate fluoride 
AS artificial saliva 
CFLM confocal laser microscopy 
CFU colony forming units 
CHX chlorhexidine 
CI confidence interval 
CR composite resin 
F  fluoride 
FAOT fixed appliance orthodontic treatment 
F-CR fluoride containing composite resin 
GI gingival index 
GIC  glass-ionomer cement 
IC ion chromatography 
ICC intra class correlation 
JPEG joint photographic expert group 
MDI 
MFP 
multiple deprivation index 
mono-fluoro-phosphate 
MH micro-hardness 
MR micro-radiography 
MW mouth-wash 
PF preventive fraction 
PI plaque index 
PLM polarised light microscopy 
QLF™ quantitative light fluorescence 
RM-GIC  resin modified glass-ionomer cement 
SD standard deviation 
SE standard error 
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SEM  scanning electron microscopy 
SnF2 stannous fluoride 
SRFGD(s) slow-release fluoride glass device(s) 
TB tooth-brushing 
TIFF tagged image file format 
TMR  transverse micro radiography 
TP tooth-paste 
UTM universal testing machine 
WSL(s) white spot lesion(s) 
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12.12 Satisfaction Questionnaire for Participants 
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12.13 Randomisation codes 
Females Males
ID Group ID Group
1 A 1 A
2 A 2 A
3 A 3 B
4 A 4 B
5 B 5 A
6 A 6 A
7 A 7 A
8 A 8 B
9 B 9 A
10 A 10 B
11 A 11 B
12 A 12 A
13 B 13 B
14 B 14 B
15 A 15 B
16 A 16 B
17 A 17 A
18 B 18 B
19 B 19 A
20 B 20 B
21 A 21 A
22 A 22 A
23 B 23 B
24 B 24 B
25 B 25 A
26 B 26 A
27 B 27 B
28 B 28 B
29 B 29 A
30 B 30 A
31 B 31 B
32 B 32 B
33 A 33 B
34 B 34 A
35 B 35 A
36 A 36 A
37 A 37 B
38 B 38 B
39 B 39 B
40 B 40 A
41 A 41 A
42 B 42 A
43 A 43 B
44 A 44 B
45 A 45 A
46 B 46 A
47 A 47 B
48 A 48 A
49 B 49 A
50 A 50 B
51 B 51 B
52 A 52 B
53 A 53 B
54 B 54 B
55 A 55 A
56 B 56 A
57 B 57 A
58 B 58 B
59 A 59 A
60 A 60 A  
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